Archives and Modern Manuscripts Finding Aids

Box | Folder Title

Series 1: Correspondence, 1951-2008 [series]:

Individuals, 1955-2002 [subseries]:

1 1-2
General correspondence, 1990-2002

1 3
Agranoff, Bernard William, 1996-2001

1 4
Asbury, Arthur K., 1989-1990

1 5
Assadi, Amir H., 1999-2000

1 6
Bakalova, R., 2002

1 7
Barnett, H. J. M., 1982

1 8
Baron, J. C., 1992-1994

1 9
Beierwaltes, William H., 1978-1983

1 10
Blakemore, Colin, 1975-82

1 11
Blasberg, Ronald G., 1989

1 12
Brier, Alan, 1993

1 13
Briggs, Josie, 1994

1 14
Clausen, Torben, 1999

1 15
Collett, Camile, 1997

1 16
Collins, Robert C., 1975-1982

136 1
Copperman, Reuben, 1955

1 17
Cowan, W. Maxwell, 1980-1985

1 18
Ermentini, Augusto, 1983

1 19
Farkas, Tibor, 1988-1991

1 20
Fieschi, Cesare, 1971-1982

1 21
Freedman, Alfred M., 1982-1992

1 22
Gjedde, Albert, 1986

1 23
Goldenson, David A., 1993

1 24
Greger, Rainer, 1991

1 25
Grillin, J. Christian, 1986-1991

136 2
Gross, Paul, 1991

1 26
Hamprecht, B., 1989

1 27
Harper, A. Murray, 1990

1 28
Hassan, M. H. A. (TWAS), 1994

1 29
Hertz, Leif, 1995

1 30-31
Holden, James E., 1987-1988

1 32
Horrocks, Lloyd A., 1983-1988

1 33
Hossman, K.-A., 1988-1990

1 34
Ibrahim, Michael A., 1995

1 35
Ingvar, David H., 1977-1993

1 36
Ishimura, Yusuru, 1996

1 37
Kelley, William N., 1991

1 38
Kennedy, Charles, 1990

1 39
Kornetsky, Conan, 1985-1988

1 40
Kornhuber, Hans H., 1992

1 41-42
Kuschinsky, Wolfgang, 1992-1996

1 43
Kuwabara, Hiroto, 1995-1996

1 44
Landau, William M., 1985

1 45-46
Lassen, Niels A., 1988-1993

1 47
Lees, Graham V., 1998

1 48
Lombardi, Vincenzo, 1992

1 49
Lunt, George G., 1995

1 50
McLaughlin, Alan, 1997

1 51
Moisand, Francoise, 1992

1 52
Mori, Kentaro, 1992-1996

1 53
Nunez, Jacques, 1968-1993

1 54
Nunez, Jeanne, 1991

1 55
Osborne, Peter, 1996

1 56
Phelps, Michael E., 1978, 1992-1994

1 57
Plum, Fred, 1978-1987

1 58
Prusiner, Stanley B., 1975-1985

1 59
Raichle, Marcus E., 1988

1 60
Reivich, Martin, 1972, 1993-1995

152 27
Rivlin, Richard, 1965

1 61
Roberts, Eugene, 1994

1 62
Sakuta, T., 1996

1 63
Schmidt, Jack, 1995

1 64
Schuier, F. J., 1993

152 28
Schwartz, William, 1987

1 65
Siesjo, Bo K., 1986-1990

152 29
Siegel, Edward, 1967

1 66
Smith, Carolyn B., 1996

1 67
Spencer, Dennis D., 1998

1 68
Tobin, allan J., 1985-1986

1 69
Toga, Arthur W., 1995

1 70
Vaalburg, W., 1997

1 71
Van Brocklin, Henry F., 1992-1993

1 72
Vertes, Robert P., 1994

1 73
Wallerstein, Melvin J., 1995-1996

1 74
Wang, Quong, 1991

1 75
Wechsler, W., 1995-1996

1 76
Wolf, Alfred P., 1993-1995

1 77
Yudkoff, Marc, 1991

Organizations, 1956-2003 [subseries]:

1 78
Academic Press, Inc., 1995

1 79
Alliance for Aging Research, 1986-1992

1 80
Encyclopedia of Neuroscience, 2001-2002

1 81
Ernest Gallo Clinic and Research Center, 1982-1989

136 3
Georgetown University (Clinical Professor), 1980-1991

1 82
Harshaw Chemical Company, 1961

1 83
Journal of Cerebral Blood Flow and Metabolism, 1991-2002

1 84
Journal of Neurochemistry, 1997-1998

1 85
Journal of Neuroscience, 1993-1998

1 86
Larco Nuclear Instrument Company, 1956

1 87
Max-Planck-Institut, 1986-1999

1 88
MRC Cyclotro Unit, Hammersmith Hospital, 1991-1993

1 89
Narsad Research, 1993-1998

1 90
National Academy of Sciences -- Detection of Alzheimer amyloid lesions in transgenic mice by magnetic resonance imaging, 2001

1 91
National Academy of Sciences -- Poly (ADP-ribose) glycohydrolase mediates oxidative and excitoxic neuronal death, 2001

1 92
National Institute on Mental Health -- Ad hoc committee, 1956

1 93
Ravan Press, 1991-1993

1 94
The Royal Society of Medicine Foundation, Inc., 1996

136 4
The Science and Technology Foundation of Japan, 1998-2001

1 95
University of Michigan -- Mental Health Research Institute, 2004

1 96
University of Pennsylvania -- Scientific advisory committee, 1975-1984

1 97
University of Pennsylvania -- PET Center, 1987-1993

1 98
University of Queensland, 1984

1 99
W. M. Keck Foundation, 1994-1996

1 100
The Wellcome Trust -- Prof. P. J. Goadsby, 1994-2002

2 1
Proceedings of the National Academy of Sciences -- A betal-40-related reduction in functional hypermia neocortex during somatosensory activation, 2000

2 2
Proceedings of the National Academy of Sciences -- Detection of Alzheimer amyloid lesions in transgenic by magnetic resonance imaging, 2001

2 3-4
Proceedings of the National Academy of Sciences -- Downregulation of Parkin protein in transcient focal cerebral ischemia, 2002

2 5
Proceedings of the National Academy of Sciences -- Editor, John Malloy, Ph.D., 1995-1999

2 6
Proceedings of the National Academy of Sciences -- Igfl regulates developing brain glucose metabolism, 2000

2 7
Proceedings of the National Academy of Sciences -- Imaging transcriptional regulation of p53 dependent genes with positron emission tomography in vivo, 2001

2 8
Proceedings of the National Academy of Sciences -- Increased rates of cerebral glucose metabolism in a mouse model of fragile X mental retardation, 2002

2 9
Proceedings of the National Academy of Sciences -- Involvement of neurogranin in the modulation of calcium, 2000

2 10
Proceedings of the National Academy of Sciences -- Mucosal tolerance to E-selectin provides cell-mediated protection against ischemic brain injury, 2003

Subjects, 1951-2003 [subseries]:

136 5
Alcohol Dehydrogenase, 1968

2 11
Brain research, 1996-2002

2 12
Cerebral blood flow (CBF) -- KR79 administrative and health physics, 1951-1956

2 13
CBF -- KR79 in epilepsy, 1951-1956

2 14
CBF -- Administration, 1954-1957

2 15
CBF -- KR85, 1957-1958

2 16
"Circular to all authors of Human physiology", 1991-1995

2 17
Collaboration, 1988-1992

136 6
Fasting and Brain Metabolism, 1969-1973

136 7
Parking Suspension, 1959

2 18-19
Personnel position inquiries, 1993-2003

2 20
Problems within laboratory, 1990-2001

2 21
Publication correspondence, 1960-1961

Nomination Files, 1985-2008 [subseries]:

143 1
Nobel Prize in Physiology or Medicine -- [name redacted], 1985-2002 [RECORDS CLOSED UNTIL 2060-2077]

143 2
National Medal of Science -- [name redacted], 1990-1995 [RECORDS CLOSED UNTIL 2065-2070]

49 1
Lasker award -- [name redacted], 1991-1996 [RECORDS CLOSED UNTIL 2066-2071]

143 3
Japan Prize -- [name redacted], 1993-1996 [RECORDS CLOSED UNTIL 2068-2071]

49 2
Grant award -- [name redacted], 1993-2003 [RECORDS CLOSED UNTIL 2068-2078]

49 3
Lasker award -- [name redacted], 1994 [RECORDS CLOSED UNTIL 2069]

143 4
National Academy of Sciences (NAS) and Institute of Medicine (IOM) -- Section 24 Nominations -- [name redacted], 1995-1997, 2005 [RECORDS CLOSED UNTIL 2070-2072, 2080]

143 5
Keio University Prize -- [name redacted], 1996-1998 [RECORDS CLOSED UNTIL 2071-7073]

49 4
Lasker award -- [name redacted], 1997-2002 [RECORDS CLOSED UNTIL 2072-2077]

49 5
Lasker award -- [name redacted], 1998-1999 [RECORDS CLOSED UNTIL 2073-2074]

143 6
American Neurological Association -- [name redacted], 2004-2005 [RECORDS CLOSED UNTIL 2079-2080]

143 7
American Neurological Association -- [name redacted], 2004-2006 [RECORDS CLOSED UNTIL 2079-2081]

143 8
National Academy of Sciences (NAS) and Institute of Medicine (IOM) -- Section 24 Nominations, 2005 [RECORDS CLOSED UNTIL 2080]

143 9
National Academy of Sciences (NAS) and Institute of Medicine (IOM) -- Section 28 Nominations, 2005 [RECORDS CLOSED UNTIL 2080]

143 10
American Philosophical Society -- [name redacted], 2007 [RECORDS CLOSED UNTIL 2082]

143 11
American Neurological Association -- [name redacted], 2008 [RECORDS CLOSED UNTIL 2083]

Series 2: Experiment Data, 1949-2003 [series]:

Experiments by Series, 1949-2003 [subseries]:

AE series, 1975 [subseries]:

2 22
AE1, 4/3/1975

2 23
AE2, 4/4/1975

2 24
AE3(discarded), 4/9/1975

2 25
AE4, 4/10/1975

2 26
AE5, 4/14/1975

2 27
AE6, 4/17/1975

2 28
AE7, 4/28/1975

2 29
AE8, 5/7/1975

2 30
AE9, 5/8/1975

2 31
AE10, 5/19/1975

2 32
AE11 (discarded), 5/20/1975

2 33
AE12, 5/22/1975

AMP series, 1976 [subseries]:

2 34
AMP -- behavior, 1976

2 35
D-AMP-DG-1, 6/8/1976

2 36
D-AMP-DG-2, 6/16/1976

2 37
D-AMP-DG-3, 6/18/1976

2 38
D-AMP-4, 8/26/1976

2 39
D-AMP-5, 8/26/1976

2 40
D-AMP-6, 9/17/1976

2 41
D-AMP-7, 12/23/1976

2 42
D-AMP-8, 12/23/1976

2 43
D-AMP-DG-101, 6/19/1976

2 44
D-AMP-102, 6/28/1976

2 45
D-AMP-103, 7/3/1976

2 46
D-AMP-104, 7/3/1976

2 47
D-AMP-105, 7/6/1976

2 48
D-AMP-106, 7/7/1976

2 49
D-AMP-107, 7/10/1976

2 50
D-AMP-108, 7/10/1976

2 51
D-AMP-109, 7/20/1976

2 52
GU-BR, 1976

3 1
L-AMP-DG-1, 6/12/1976

3 2
L-AMP-2, 10/22/1976

3 3
L-AMP-3, 12/20/1976

3 4
L-AMP-4, 12/21/1976

3 5
L-AMP-5, 12/22/1976

3 6
L-AMP-6, 12/22/1976

3 7
L-AMP-7, 12/23/1976

3 8
L-AMP-101, 7/12/1976

3 9
L-AMP-102, 7/12/1976

3 10
L-AMP-103, 7/15/1976

3 11
L-AMP-104, 7/17/1976

3 12
L-AMP-105, 7/17/1976

Antipyrine series, 1969-1976 [subseries]:

3 13
Antipyrine [ ]-CBF control 1, 3/29/1976

3 14
Antipyrine [ ]-CBF control 2, 4/2/1976

3 15
Antipyrine [ ]-CBF control 3, 4/3/1976

3 16
Antipyrine c14, [ ]-CBF control 4, 4/5/1976

3 17
Antipyrine c14, [ ]-CBF control 5, 4/6/1976

3 18
Antipyrine C14, [ ]-CBF control 6, 4/7/1976

3 19
Antipyrine partition coefficient in dogs, 1969-1970

3 20
Antipyrine partition coefficient in rats [photograph, negative], 1970

3 21
ARF-8A, LCBF-antip.-1', control, 1975

3 22
Chromatography on antipyrine, undated

3 23
Laplace trsnaforms for antip. Sq. wave, 1975-1976

3 24
Series [ ] -- IOD: IODO-antip. part. coeff. in rats -- data corrected, 1976

3 25
Series [ ] -- IOD; IODO-antip. part. coeff. in rats -- discarded, 1976

3 26
Technical information on IODO-antipyrine, 1976

AR series, 1974-1975 [subseries]:

3 27
AR-1, P-30' -- 60 uc, experimental, 1974

3 28
AR-1A, P-30' -- 60 uc control, 1974

3 29
AR-2, P-30' -- 60 uc, experimentals, 1974

3 30
AR-3, P-30' -- 60 uc, experimentals, 1974

3 31
AR-3A, P-30' -- 60 uc, control, 1974

3 32
AR-4, P-30' -- 80 uc, experimentals, 1974

3 33
AR-4A, P-30' -- 80 uc, control, 1974

3 34
AR-5, P-30' -- 80 uc, experimentals, 1974

3 35
AR-5A, P-30' -- 80 uc, control, 1974

3 36
AR-6, P-30' -- 80 uc, experimentals, 1974

3 37
AR-6A, P-30' -- 80 uc, control, 1974

3 38
AR-7, P-30' -- 80 uc, experimentals, 1974

3 39
AR-8, P-30' -- 80 uc, experimentals, 1974

3 40
AR-9, anesthesia -- P-30' -- 80 uc, experimentals, 1974

3 41
AR-10, anesthesia -- P-30' -- 80 uc, experimentals, 1974

3 42
AR-11, experimentals, 11/6/1975

3 43
AR-12, experimentals, 12/6/1975

3 44
AR-13, experimentals, 7/16/1975

ARF series, 1974-1976 [subseries]:

3 45
ARF1 -- LCBF + BARB, 3/20/1974

3 46
ARF2 -- LCBF + BARB, 3/20/1974

3 47
ARF3 -- LCBF + BARB, 3/21/1974

3 48
ARF4 -- LCBF + BARB, 3/21/1974

3 49
ARF5, LCBF + BARB, 3/23/1974

3 50
ARF-6, 6/16/1975

3 51
ARF-7, 6/19/1975

3 52
ARF-8, 6/23/1975

3 53
ARF-11, 6/21/1976

3 54
ARF-12, 6/21/1976

3 55
ARF-13, 6/23/1976

3 56
ARF-14, 6/23/1976

3 57
ARF-15, 6/30/1976

3 58
ARF-16, 7/6/1976

ATP series, 1964-1973 [subseries]:

3 59
ATP assay protocol, undated

3 60
ATP assays of factor preps., 1966

3 61
Effects of thyroid hormone in vivo on protein biosynthesis -- book 1T, 1964

3 62
Effects of thyroxine in vivo [photographs, negatives], undated

3 63
In vivo effect of T4 on microsomal ATP ase (I), 1971

3 64
In vivo effect of T4 on microsomal ATP ase (2), 1972

3 65
In vivo effect of T4/T3 on microsomal ATP ase (3), 1973

3 66
In vivo effect of T4/T3 on microsomal ATPase (4), 1973

4 1
In vivo experiments, undated

4 2
Microsomal ATP ase -- prep book, 1970

4 3
Microsomal ATP ase 1, Apr.-Oct. 1970

4 4
Microsomal ATP ase 2, Oct. 1970

4 5
Microsomal ATP ase 3, 1971-1972

4 6
Microsomal ATP ase 4, 1972-1973

Cat series, 1971-1981 [subseries]:

4 7
Cat 1, LCGU 30', 1971

4 8
Cat 3, LCGU 35', 1971

4 9
Anest. Cat 4, 1974

4 10
Cat 101, 11/17/1977

4 11
Cat 102, 10/20/1977

4 12
Cat 103, 10/27/1977

4 13
Cat 104, 11/17/1977

4 14
Cat 105, 11/21/1977

4 15
Cat 106, 12/1/1977

4 16
Cat 107, 12/8/1977

4 17
Cat 108, 12/15/1977

4 18
Cat 109, 12/21/1977

4 19
Cat 110, 12/29/1977

4 20
Cat 111, Jan. 12, 1978

4 21
Cat 112, 1/19/1978

4 22
Cat 113, 1/26/1978

4 23
Cat 114, 2/2/1978

4 24
Cat 115, 2/9/1978

4 25
Cat 116, 2/23/1978

4 26
Cat 117, 3/2/1978

4 27
Cat 118, 3/9/1978

4 28
Cat 119, 3/14/978

4 29
Cat 120, 3/16/1978

4 30
Cat 121, 3/23/1978

4 31
Cat 122, 3/24/1978

4 32
Cat 123, 3/28/1978

4 33
Cat 124, 3/29/1978

4 34
Cat awake, rem-4, rem-5, pc-1, 1980

4 35
Cat CBF 2, 1971

4 36
Cat, lumped constant, 1974

4 37
Normal cats, LCBF 1, 1971

4 38
Normal cat CBF 3, 1971

4 39
Normal cat CBF 4, 1971

4 40
Normal cat CBF 5, 1971

4 41
Normal -- CFG cat CBF 6, 1971

4 42
SC-1, r. eye patched + 1 PS (P-45' -- 200 uc), 1973

4 43
SC-1A, both eyes patched (P-45 -- 220 uc), 1973

4 44
Series cat: cats -- 30 min. controls, 1980-1981

4 45
Series SQ, Cat 2 -- 8 -- lumped constant in cats conscious, 1974-1976

4 46
SLC 1 (control for REM), 1975

4 47
SLC-2, control for REM, 1975

4 48
SLC-3, REM sleep cat, 1975

4 49
SLC-4, REM sleep cat, 1975

4 50
SLC-5, REM sleep cat, 1976

4 51
SQ -- Cat 1, anesth., 1974

4 52
SQ -- Cat 2, anesth., 1974

Cerebral Blood Flow (CBF) series, 1953-1993 [subseries]:

5 1
1 NMACO2 -- CBF series -- air breathing control, 1990

5 2
2 NMACO2 -- CBF series, air breathing control, 1990

5 3
3 NMACO2 -- CBF series, 5% CO2 in air, 1990

5 4
4 NMACO2 -- CBF series, 5% CO2 in air, 1990

5 5
5 NMACO2 -- CBF series -- 5% CO2 + N methyl arginine, 1990

5 6
6 NMACO2 -- CBF series -- 5% CO2 + N methyl arginine, 1990

5 7
7 NMACO2 -- CBF series, 5% C02 in air, 1990-1991

5 8
8 NMACO2 -- CBF series -- air breathing control, 1990

5 9
9 NMACO2 -- CBF series -- air + N methyl arginine, 1990

5 10
10 NMACO2 -- CBF series -- 5% CO2 + N methyl arginine, 1990

5 11
11 NMACO2 -- CBF series -- air + N methyl arginine, 1990-1991

5 12
12 NMACO2 -- CBF series -- 5% CO2 in air, 1990-1991

5 13
13 NMACO2 -- CBF series -- 5% CO2 in air, 1990-1991

5 14
14 NMACO2 -- CBF series -- 5% CO2 in air, 1990-1991

5 15
15 NMACO2 -- CBF series -- air + N methyl arginine, 1991

5 16
16 NMACO2 -- CBF series -- air breathing control, 1991

5 17
17 NMACO2 -- CBF series -- air + N methyl arginine, 1991

5 18
18 NMACO2 -- CBF series -- 5% CO2 + N methyl arginine, 1991

5 19
19 NMACO2 -- CBF series -- air breathing control, 1991

5 20
20 NMACO2 -- CBF series -- air + N methyl arginine, 1991

5 21
21 NMACO2 -- CBF series -- 5% CO2 + N methyl arginine, 1991

5 22
22 NMACO2 -- CBF series -- air + N methyl arginine, 1991

5 23
23 NMACO2 -- CBF series -- 5% CO2 in air, 1991

5 24
24 NMACO2 -- CBF series -- 5% CO2 + N methyl arginine, 1991

5 25
25 NMACO2 -- CBF series -- air breathing control, 1991

5 26
26 NMACO2 -- CBFG series -- air + N methyl arginine, 1991

5 27
27 NMACO2 -- CBF series -- 5% CO2 + N methyl arginine, 1991

5 28
28 NMACO2 -- CBF series -- 5% CO2 + N methyl arginine, 1991

5 29
29 NMACO2 -- CBF series -- 5% CO2 + N methyl arginine (30 mg/kg), 1991

5 30
30 NMACO2 -- CBF series -- - 5% CO2 + N methyl arginine (30 mg/kg), 1991

5 31
31 NMACO2 -- CBF series -- air + N methyl arginine (30 mg/kg), 1991

5 32
32 NMACO2 -- CBF series -- air + N methyl arginine (30 mg/kg), 1991

5 33
33 NMACO2 -- CBF series -- air + N methyl arginine (30 mg/kg), 1991

5 34
34 NMACO2 -- CBF series -- 5% CO2 + N methyl arginine (30 mg/kg), 1991

5 35
35 NMACO2 -- CBF series -- 5% CO2 + N methyl arginine (30 mg/kg), 1991

5 36
36 NMACO2 -- CBF series -- air + N methyl arginine (30 mg/kg), 1991

5 37
37 NMACO2 -- CBF series -- air + N methyl arginine (30 mg/kg), 1991

5 38
38 NMACO2 -- CBF series -- air + N methyl arginine (30 mg/kg), 1991

5 39
39 NMACO2 -- CBF series -- air + saline, 1991

5 40
40 NMACO2 -- CBF series -- 5% CO2 + N methyl arginine (100 mg/kg), 1991

5 41
41 NMACO2 -- CBF series -- 5% CO2 + N methyl arginine, 1991

5 42
42 NMACO2 -- CBF series -- air + N methyl arginine (100 mg/kg), 1991

5 43
43 NMACO2 -- CBF series -- air + NMA (100 mg/kg), 1991

5 44
44 NMACO2 -- CBF series -- 5% CO2 + NMA (100 mg/kg), 1991

5 45
45 NMACO2 -- CBF series -- 5% CO2 + NMA (100 mg/kg), 1991

5 46
46 NMACO2 -- CBF series -- air + NMA (100 mg/kg), 1991

5 47
47 NMACO2 -- CBF series -- air + NMA (100 mg/kg), 1991

5 48
48 NMACO2 -- CBF series -- 5% CO2 + NMA (100 mg/kg), 1991

5 49
49 NMACO2 -- CBF series -- 5% CO2 + NMA (100 mg/kg), 1991

5 50
50 NMACO2 -- CBF series -- air + NMA (100 mg/kg), 1991

5 51
51 NMACO2 -- CBF series -- air + NMA (100 mg/kg), 1991

5 52
52 NMACO2 -- CBF series -- 5% CO2 + NMA (100 mg/kg), 1991

5 53
53 NMACO2 -- CBF series -- air + NMA (100 mg/kg), 1991

5 54
54 NMACO2 -- CBF series -- air + saline, 1991

5 55
55 NMACO2 -- CBF series -- air + saline (eliminated), 1991

5 56
56 NMACO2 -- CBF series -- air + saline, 1991

5 57
57 NMACO2 -- CBF series -- air breathing control, 1991

5 58
58 NMACO2 -- CBF series -- 5% CO2 in air, 1991

5 59
59 NMACO2 -- CBF series -- 5% CO2 in air, 1991

5 60
60 NMACO2 -- CBF series -- air breathing control, 1991

5 61
61 NMACO2 -- CBF series -- air breathing control, 1991

5 62
62 NMACO2 -- CBF series -- 5% CO2 in air, 1991

5 63
63 NMACO2 -- CBF series -- saline + 5% CO2, 1991

5 64
64 NMACO2 -- CBF series -- saline + air, 1991

5 65
65 NMACO2 -- CBF series -- saline + air, 1991

5 66
66 NMACO2 -- CBF series -- saline + 5%CO2, 1991

5 67
67 NMACO2 -- CBF series -- air + NMA (30 mg/kg), 1991

5 68
68 NMACO2 -- CBF series -- air + NMA (10 mg/kg), 1991

5 69
69 NMACO2 -- CBF series --5% CO2 + NMA (10 mg/kg), 1991

5 70
70 NMACO2 -- CBF series -- air + NMA (10 mg/kg), 1991

5 71
71 NMACO2 -- CBF series -- 5% CO2 + NMA (10 mg/kg), 1991

5 72
72 NMACO2 -- CBF series -- air + NMA (10 mg/kg), 1991

5 73
NMA-73, NMA 10 mg/kg + air, 1992

5 74
NMA-74, NMA 10 mg/kg I.V + air, 1992

5 75
NMA-75, NMA 30 mg/kg I.V. + air, 1992

5 76
NMA-76, NMA 10 mg/kg I.V. + 5% CO2, 1992

5 77
77 NTRO-1, CO2 and saline I.V., 1992

5 78
78 NTRO-2, CO2 and nitro, 1992

5 79
79 NTRO-3, air and nitro 30 mg/kg i.v., 1992

5 80
80 NTRO-4, air and nitro, 1992

5 81
81 NTRO-5, CO2 and nitro, 1992

5 82
82 NTRO-6, CO2 and saline i.v., 1992

5 83
83 NTRO-7, CO2 and saline i.v., 1992

6 1
84 NTRO-8, CO2 and nitro, 1992

6 2
85 NTRO-9, air and nitro, 1992

6 3
86 NTRO-10, CO2 and nitro 30 mg/kg i.v., 1992

6 4
87 NTRO-11, air + nitro 30 mg/kg i.v., 1992

6 5
88 NTRO-12, CO2 and nitro 30 mg/kg i.v., 1992

6 6
89 NTRO-13, air and nitro, 1992

6 7
90 NTRO-14, air and nitro, 1992

6 8
91 NTRO-15, CO2 and nitro, 1992

6 9
92 NTRO-16, CO2 and nitro, 1992

6 10
93 NTRO-17, 5% CO2 and nitro 30 mg/kg, 1992

6 11
95 NTRO-19, 5% CO2 and nitro 30 mg/kg i.v., 1992

6 12
96 NTRO-20, nitro-topical, 1992

6 13
97 NTRO-21, nitro-topical, 1992

6 14
98 NTRO-22, nitro-topical, 1992

6 15
98 NTRO-23, nitro-topical, 1992

6 16
100 NTRO-24s, air and nitro 30 mg/kg, 1993

6 17
101 NTRO-25s, air + nitro 30 mg/kg, 1993

6 18
102 NTRO-26s, 5% CO2 and nitro 30 mg/kg i.v., 1993

6 19
103 NTRO-27s, nitro 30 mg/g i.v. and 5% CO2, 1993

6 20
104 (28), CO2 and NTRO, 1993

6 21
105 (29), CO2 and NTRO, 1993

6 22
106 (30), air and NTRO, 1993

6 23
107 (31), air and NTRO, 1993

6 24
NTRO 108, chronic i.p. and CO2, 1993

6 25
NTRO 109, chronic i.p. and CO2, 1993

6 26
NTRO 110, chronic i.p. and air, 1993

6 27
NTRO 111, chronic i.p. and air, 1993

6 28
NTRO 112, chronic i.p. and air, 1993

6 29
NTRO 113, chronic i.p. and CO2, 1993

6 30
NTRO 114, chronic i.p. and CO2, 1993

6 31
NTRO 115, chronic i.p. and CO2, 1993

6 32
NTRO 116, chronic i.p. and air, 1993

6 33
NTRO 117, chronic i.p. and air, 1993

6 34
NTRO 118, chronic i.p. and air, 1993

6 35
NTRO 119, chronic i.p. and CO2, 1993

6 36
NTRO 120, saline chronic i.p. and CO2, 1993

6 37
NTRO 121, saline chronic i.p. and CO2, 1993

6 38
NTRO 122, saline chronic i.p. and air, 1993

6 39
NTRO 123, saline chronic i.p. and air, 1993

6 40
NTRO 124, saline chronic i.p. and air, 1993

6 41
NTRO 125, saline chronic i.p. and CO2, 1993

6 42
NTRO 126, 1993

6 43
NTRO 127, 1993

6 44
NTRO 128, 1993

6 45
NTRO 129, 1993

6 46
NTRO 130, 1993

6 47
NTRO 131, saline chronic i.p. and CO2, 1993

6 48
NTRO 132, saline chronic i.p. and CO2, 1993

6 49
NTRO 133, saline chronic i.p. and CO2, 1993

6 50
14c-NMA distribution, 1993

6 51
Brain tissue NMA assay, 1992

6 52
Calculations for CBF (Kety-Schmidt), undated

6 53
CBF -- ischemia experiments, 1980

6 54
CBF -- LSD -- normals, 1954-1955

6 55
CBF -- n.20 -- normal young, 1957-1958

6 56
CBF -- nitrous oxide -- Pitressin, 1956

6 57
CBF -- nitrous oxide -- children [photographs], 1957

6 58
CBF -- thyroid disease, undated

6 59
CBF aged -- continued, 1956-1957

6 60
CBF exp., undated

6 61
CBF lysergic acid [photographs], 1955

6 62
Cerebral blood flow, 1957-1958

6 63
Cerebral blood flow -- book II, 1954-1957

6 64
Cerebral blood flow 3, 1955

6 65
Changes in CBF during REM sleep (fig. 3) (from Reivitch, et. al.) [slides], 1977

6 66
Chemical assay in NMA study, 1992

6 67
CO2 study -- local CBF, undated

6 68
CBF -- LSD -- schizophrenia, 1954-1955

6 69
KR 79 CBF studies [photographs], 1953-1955

6 70
Local C.B.F III, 1954-1955

6 71
Local C.B.F. II, 1953-1954

6 72
Local C.B.V IV, 1955-1957

152 16
Hyperthyroids/hypothyroids, 1950-1951

152 17
[Thyroid hormones], [c.1950s]

152 18
Norepinephrine studies, 1950-1951

152 19-20
The role of L-Norepinephrine in the treatment of shock, 1953

152 21
Sleep paper, [1952-1953]

152 22
Sleep study, [1950-1951]

152 23
Cerebral blood flow mental exercises, [1952-1954]

6 73
NMA Co2 series, undated

6 74
NMA2DG series: animal 01 control, 1991

6 75
NMA2DG series: animal 02, exp. NMA 3 mg., 1991

6 76
NMA2DG series: animal 3, exp. NMA 3 mg/kg, 1991

6 77
NMA2DG series: animal 4 control, 1991

6 78
NMA2DG series: animal 05, exp. NMA 3mg/kg, 1991

6 79
NMA2DG series: animal 06 control, 1991

6 80
NMA2DG series: animal 07, exp. NMA 3mg/kg, 1991

6 81
NMA2DG series: animal 08 control, 1991

6 82
NMA2DG series: animal 09 control, 1991

6 83
NMA2DG series: animal 10 control (eliminated), 1991

7 1
NMA2DG series: animal 11 control, 1991

7 2
NMA2DG series: animal 12 control, 1991

7 3
NMA2DG series: animal 13 control, 1991

7 4
NMA2DG series: animal 14, exp. NMA 100 mg/kg, 1991

7 5
NMA2DG series: animal 15, exp. NMA 100 mg/kg, 1991

7 6
NMA2DG series: animal 16 control, 1991

7 7
NMA2DG series: animal 17, exp. NMA 100 mg/kg, 1991

7 8
NMA2DG series: animal 18 control, 1991

7 9
NMA2DG series: animal 19, exp. NMA 100 mg/kg, 1991

7 10
NMA2DG series: animal 20, exp. NMA 100 mg/kg, 1991

7 11
NMA2DG series: animal 21, exp. NMA 100 mg/kg, 1991

7 12
NMACO2 summaries, 1992

7 13
NMA-DG, data sheet, 1991-1992

7 14
Regional cerebral blood flow (Tbl 2) (from Reivitch, et. al.), 1977

CI* series, undated

7 15
Ci *(t)/Cp*(t) v.s stretch time (pulse experiments), 1979

7 16
Ci ct/Cp* vs. real time or stretch time -- weighted average, 1979-1985

7 17
Ci*(t)/Cp*(t) vs. stretch time (pulse experiments), undated

7 18-19
Local tissue 14c concentration (gray) Ci*Ct/Cp* (gray) [folder 1 of 2], 1979-1986

7 20
Local tissue 14c concentration (white) -- Ci ct/Cp* (white), 1975-1985

7 21
Lt Cp*dt -- pulse exp., 1979

7 22
Pulse (mori) -- local Ci* -- ci*/Cp*, 1979-1984

7 23
Square wave experiments -- Ci*(t)/Cp*(t) vs. stretch time -- vs. real time Ci*(t)/Cp*, undated

7 24
Weighted average -- Ci*(t)/Cp*(t) vs. stretch time -- pulse experiments, 1979

CR series, 1972-1976 [subseries]:

7 25
CB-4, B-20 uc -- 45', CO2 -- 86', 1975

7 26
CB-5, B-20 uc -- 45', CO2 -- 86', 1975

7 27
CB-6, Pul. -- 20 uc -- 45', CO2 -- 90', 1975

7 28
CB-7, LCGU-45' -- 30 uc, CO2 -- 75', 1975

7 29
CB-8, discarded, 1975

7 30
CB-9, LCGU -- 45' -- 30 uc, CO2 -- 75', 1975

7 31
Series CRO: 5% CO2, 45' exposure, undated

7 32
CR-1, LCGU + CO2, P-30' 80 uc, 1974

7 33
CR-2, LCGU + CO2, P-30' -- 80 uc, 1974

7 34
CR-3, LCGU + CO2, P-30' -- 80 uc, 1974

7 35
CR-4, LCGU + CO2, P-33' -- 90 uc, 1974

7 36
CR-5, LCGU + CO2, P-30' -- 90 uc, 1974

7 37
CR-101, LCGU -- 30' -- 75 uci, CO2 -- 45', 1975

7 38
CR-102, LCGU -- 30' -- 75 uci, CO2 -- 45', 1975

7 39
CR-103, LCGU -- 30' -- 75 uci, CO2 -- 45', 1975

7 40
CR-104, LCGU -- 30' -- 50 uci, CO2 -- 45', 1975

7 41
CR-105, LCGU -- 30' -- 70 uci, CO2 -- 45', 1975

7 42
CRF-1, 85 uc, LCBF + CO2-74 min., 1974

7 43
CRF-2, 85 uc, LCBF + CO2 -- 70', 1974

7 44
CRF-3, 85 uc, LCBF + CO2 -- 45', 1974

7 45
CRF-4, 68 uc, LCBF + CO2 -- 48', 1974

7 46
CRF-5, 68 uc, LCBF + CO2 -- 45', 1974

7 47
CRF-6, 85 uc, LCBF + CO2 -- 41', 1974

7 48
CRF-7, 85 uc, LCBF + CO2 -- 26', 1974

7 49
CRF-8, 85 uc, LCBF + CO2 -- 38', 1974

7 50
CRF-9, 85 uc, LCBF + CO2 -- 43', 1974

7 51
CRF-10, 85 uc, LCBF + CO2 -- 42', 1974

7 52
CRF-11, 85 uc, LCBF + CO2 -- 11', 1975

7 53
CRF-12, 85 uc, LCBF + CO2 -- 12', 1975

7 54
CRF-13, 85 uc, LCBF + CO2 -- 12', 1975

7 55
CRF-14, 85 uc, LCBF + CO2 -- 16', 1975

7 56
CRF-15, 68 uc, LCBF + CO2 -- 14', 1975

7 57
CRF-101, LCBF -- 1', 10% CO2 -- 45', 1975

7 58
CRF-102, LCBF -- 1', 10% CO2 -- 45', 1975

7 59
CRF-103, LCBF -- 1', 10% CO2 -- 45', 1975

7 60
CRF-104, LCBF -- 1', 10% CO2 -- 45', 1975

7 61
CRF-105, LCBF (Ant. 1'), 10% CO2 -- 45', 1975

7 62
Series CRF 111-115 : 10% CO2 + 10' exposure, 1975

7 63
CRF-201, 20% CO2, 1976

7 64
L.C.B.F. : effects of CO2 in puppy, 1972

DEX series, 1979 [subseries]:

8 1
Dex-1, 1/30/1979

8 2
Dex-2, 3/12/1979

8 3
Dex-3, 3/14/1979

8 4
Dex-4, 3/16/1979

8 5
Dex-5, 4/19/1979

8 6
Dex-Px-1 (21 mg/kg), 1/15/1979

8 7
Dex-Px-2 (21 mg/kg), 3/12/1979

8 8
Dex-Px-3 (21 mg/kg/min.), 3/14/1979

8 9
Dex-Px-4 (21 mg/kg), 3/16/1979

8 10
Dex-Px-5 (21 mg/kg), 3/21/1979

Deoxyglucose (DG) series, 1973-1979 [subseries]:

8 11
% of free DG in grey and white matter, 1977

8 12
DG-1, 30' -- B, 1973

8 13
DG-2 (C14), 1973

8 14
DG-3, 45' cont., 1973

8 15
DG-101, 30' -- B, 1973

8 16
DG-102, B -- 30' -- 51 uc, 1973

8 17
DG-103, B-45'-76 uc, 1973

8 18
DG-104, B-45' -- 76 uc, 1973

8 19
DG-105 B-120' (51 uc x 1 1/2'), 1973

8 20
DG-106, B-45' -- 51 uc, 1973

8 21
DG-107 B-120 (51 uc x 1 1/2'), 1973

8 22
DG-108, B-45' -- 51 uc, 1973

8 23
DG-111, B-75' -- 51 uc, 1973

8 24
DG-112, B-75 -- 51 uc, 1973

8 25
DG-113, B-90' -- 51 uc, 1973

8 26
DG-114, B-90' -- 51 uc, 1973

8 27
DG-115, LCGU -- control 45', 1975

8 28
DG-116, LCGU -- control 45' (30 uc), 1975

8 29
DG-117, LCGU -- 30' -- 50 uc, 1975

8 30
DG-118, LCGU -- 30', control, 1975

8 31
DG-119, LCGU -- 30' -- 50 uc, control, 1975

8 32
DG-120, LCGU -- 30' -- 50 uc, control, 1975

8 33
DG-121, normal control 45', 1976

8 34
DG-125, LCGU normal control rat, 30', 1976

8 35
DG-126, LCGU -- normal control rat 45', 1976

8 36
DG-127, LCGU -- normal control, 45', 1976

8 37
DG-128, LCGU -- normal control rat, 45', 1976

8 38
DG-129, LCGU -- normal control rat, 45', 1976

8 39
DG-130, LCGU -- normal control, 30', 1976

8 40
DG-131, LCGU -- normal control, 30', 1976

8 41
DG-132, LCGU normal control, 30', 1976

8 42
DG-133, LCGU -- normal control, 30', 1976

8 43
DG-134, LCGU -- normal control rat, 45' (discarded), 1976

8 44
DG-135, LCGU -- light flow rate of anesthetic gas mixture, 45', 1976

8 45
DG-137, LCGU -- tight mask + high flow rate of anesthetic gas mixture, 30', 1976

8 46
DG-138, normal control rat, 45', 1976

8 47
DG-141, high flow rate of gas mix with tight mask, 30', 1976

8 48
DG-142, low flow rate of gas mix with loose mask, 30', 1976

8 49
DG-143, normal control rat, 45', 1976

8 50
DG-144, normal control rat, 45', 1976

8 51
DG-145, normal control rat, 45', 1976

8 52
DG-146, normal control rat, 45', 1976

8 53
DG-147, normal control rat, 45' (discarded), 1976

8 54
DG-170, 8/16/1977

8 55
DG-182, 45 min. (C.K.), 7/27/1978

8 56
DG-183, 30 min. (C.K.), 7/27/1978

8 57
DG-184, 20 min. C.K., 7/27/1978

8 58
DG-185, 45 m in. (C.K.), 7/31/1978

8 59
DG-186, 30 min. (C.K.), 7/31/1978

8 60
DG-190, 45 min. (C.K.), 9/11/1978

8 61
DG-191, 20' control, 9/11/1978

8 62
DG-192, 60 min. (C.K.), 9/14/1978

8 63
DG-193, 45 min. (C.K.), 9/18/1978

8 64
DG-194, 90 min. (C.K.), 9/21/1978

8 65
DG-195, 20 min. C.K., 9/21/1978

8 66
DG-196, 20 min. C.K., 10/2/1978

8 67
DG-198, 30 min. (C.K.), 10/5/1978

8 68
DG-199, 20 min. C.K., 10/16/1978

9 1
DG-200, 30 min (C.K.), 10/16/1978

9 2
DG-201, 45 min. (C.K.), 10/19/1978

9 3
DG-201, 5' -- C -- 51 uc, 1973

9 4
DG-202, 60 min (C.K.), 10/19/1978

9 5
DG-202., 5' -- C -- 51 uc, 1973

9 6
DG-203, 10' -- C 39 uc, 1973

9 7
DG-203, 90 min., 10/23/1978

9 8
DG-204, 10' -- C 39 uc, 1973

9 9
DG-204, 60 min., 10/23/1978

9 10
DG-205, 10' -- C -- 39 uc, 1973

9 11
DG-205, 60 min. control, 1978

9 12
DG-206, 5' -- C 51 uc, 1973

9 13
DG-207, 10' -- C -- 39 uc, 1973

9 14
DG-207, 60 min., 12/22/1978

9 15
DG-208, 20' -- C -- 34 uc, 1973

9 16
DG-209, 20' -- C -- 34 uc, 1973

9 17
DG-209, 45 min. (C.K.), 12/28/1978

9 18
DG-210, 20' -- C -- 34 uc, 1973

9 19
DG-210, 30 min., 12/28/1978

9 20
DG-211, 20 min. control, 1/4/1979

9 21
DG-211, C -- 30' -- 29 uc, 1973

9 22
DG-212, 30' -- C -- 29 uc, 1973

9 23
DG-212, 90 min., 1/11/1979

9 24
DG-213, 90 min., 1/15/1979

9 25
DG-213, C -- 30' -- 29 uc, 1973

9 26
DG-214, 90 min., 1/18/1979

9 27
DG-214, C -- 45' -- 23 uc, 1973

9 28
DG-215, 90 min., 1/18/1979

9 29
DG-215, C -- 45' -- 23 uc, 1973

9 30
DG-216, C -- 1' -- 68 uc, 1973

9 31
DGX-1, BoP. -- 6 hrs., 1973

9 32
DGX-2, BoP. -- 17 hrs., 1973

9 33
DGX-3, BoP -- 24 hrs., 1973

9 34
Summary of DGX-1, DGX-2, DGX-3 data, 1973

151 4
[DG* and DG*-6-P chart with three time graph printouts, 1974, 1975, 1976

DL series, 1971-1973 [subseries]:

9 35
DL-X, 1972

9 36
Series DL1 -- DL11 : 20 mg/kg, experimentals, 1971

9 37
Series DL 1A -- DL 11A : 20 mg/kg controls, 1972

9 38
Series DL101 -- DL110 : 100 mg/kg, experimentals, 1971

9 39
Series DL201-DL206 : 50 mg/kg, experimental, 1972

9 40
Series DL207A -- DL215A : 50 mg/kg, controls, 1972

9 41
Series DL208 -- DL211 : 50 mg/kg, experimentals, 1972

9 42
Series DL213 -- DL214 : 50 mg/kg, experimentals, 1975

9 43
Series DL301 and DL302 : 50 mg/kg, experimental, 1972

9 44
Series DL301A -- DL303A : 50 mg/kg, controls, 1972

9 45
Series DL304 -- DL307 : 50 mg/kg, experimentals, 1972

9 46
Series DL306A -- DL309A : 50 mg/kg, controls, 1972-1973

9 47
Series DL-309 : 50 mg/kg, experimentals, 1973

E/E series, 1974-1975 [subseries]:

9 48
E/E 1and2, discarded, 1974

9 49
E/E 3, 1974

9 50
E/E 4, 1974

9 51
E/E 5, 1974

9 52
E/E 6, 1974

9 53
Rat E/E 7, 1974

9 54
E/E 8, 11/7/1974

9 55
E/E 9, 11/14/1974

9 56
E/E 10, 12/12/1974

9 57
E/E 11, 1974

9 58
E/E 12, 1974

9 59
E/E 13, Jan. 10, 1975

9 60
E/E 14, 1/13/1975

9 61
E/E 15, 1/17/1975

9 62
E/E 16, 1/23/1975

9 63
E/E 17, 1/27/1975

9 64
E/E 18, 2/6/1975

9 65
E/E 19, 2/10/1975

9 66
E/E 20, 2/13/1975

9 67
E/E 21, Feb. 14, 1975

9 68
E/E 26, and 27, cancelled, 1975

9 69
E/E 29 discarded, 1975

G6 series, 1985, 1987 [subseries]:

9 70
G6 pase 1, 1985

9 71
G6 pase 2, 1985

9 72
G6 pase 3, 1985

9 73
G6 pase 4, 1985

9 74
G6 pase 5, 1985

9 75
G6 pase 6, 1985

9 76
GA pase 7, 1985

9 77
G6 pase 8, 1985

9 78
G6 pase 9, 1985

9 79
G6 pase 10, 1985

9 80
G6 pase 11, 1985

9 81
G6 pase 12, 1985

9 82
G6 pase 13, 8/2/1985

9 83
G6 pase 14, 1985

9 84
G6 pase 15, 1985

9 85
G6 pase 16, 1985

9 86
G6 0ase 17, 8/5/1985

9 87
G6 pase 18, 8/5/1985

9 88
G6 pase 19, 8/5/1985

9 89
G6 pase 20, 8/5/1985

9 90
G6 pase 21, 8/1/1985

9 91
G6 pase 22, 8/6/1985

9 92
G6 pase 23, 8/6/1985

9 93
G6 pase 24, 8/6/1985

9 94
G6 pase 25, 8/7/1985

9 95
G6 pase 26, 8/7/1985

9 96
G6 pase 27, 8/7/1985

9 97
G6 pase 28, 8/7/1985

9 98
G6 pase 29, 8/8/1985

10 1
G6 pase 30, 8/8/1985

10 2
G6 pase 31, 8/8/1985

10 3
G6 pase 32, 8/8/1985

10 4
G6 pase 33, 8/9/1985

10 5
G6 pase 34, 8/9/1985

10 6
G6 pase 35, 8/9/1985

10 7
G6 pase 36, 8/9/1985

10 8
G6 pase 37, 8/10/1985

10 9
G6 pase 38, 8/10/1985

10 10
G6 pase 39, 1985

10 11
G6 pase 40, 1985

10 12
G6 pase 41, 1985

10 13
G6 pase 42 -- 60 min., 8/13/1985

10 14
G6 pase 43, 1985

10 15
G6 pase 44, 8/14/1985

10 16
G6 pase 45 -- 90 min., 8/14/1985

10 17
G6 pase 46 -- 2.5 min., 8/14/1985

10 18
G6 pase 47 -- 15 min., 8/14/1985

10 19
G6 pase 48 -- 60 min., 8/16/1985

10 20
G6 pase 49 -- 30 min., 8/16/1985

10 21
G6 pase 50 -- 15 min., 8/16/1985

10 22
G6 pase 51, 8/17/1985

10 23
G6 pase 52, 10/16/1985

10 24
G6 pase 53, 10/16/1985

10 25
G6 pase 54, 11/27/1985

10 26
G6 pase 55, 11/27/1985

10 27
G6 pase 56, 11/29/1985

10 28
G6 pase 57, 11/29/1985

10 29
G6 pase 58, 11/29/1985

10 30
G6 pase P1, 8/15/1985

10 31
G6 pase P2, 8/15/1985

10 32
G6 pase P3, 8/16/1985

10 33
G6 pase P4, 8/16/1985

10 34
G6 pase P5, 8/16/1985

10 35
G6 pase P6, 8/27/1985

10 36
G6 pase P7, 8/1985

10 37
G6 pase, 1985

10 38
G6 pase -- vol. I -- no. 1 -- no. 13, 1985

10 39
G6 pase -- vol. II -- no. 14 -- no. 25, 1985

10 40
G6 pase -- vol. III -- no. 26 -- no. 37, 1985

10 41
G6 pase -- vol. IV -- no. 38 -- no. 49, 1985

10 42
G6 pase -- P -- vol V, 1985

10 43
G6 pase -- vol. VI -- no. 50, 1985

10 44
G6 pase (square) -- anova, 1987

10 45
Physiological conditions -- G6 pase 1~58, undated

HLNC series, 1976 [subseries]:

10 46
Helen and Larry normal control series, undated

10 47
HLNC-DG-, 6/25/1976

10 48
HLNC-DG-2, discarded, 6/25/1976

10 49
HLNC-3, 6/28/1976

10 50
HLNC-4, 7/1/1976

10 51
HLNC-5, 7/2/1976

10 52
HLNC-6, 7/6/1976

10 53
HLNC-7, 7/10/1976

10 54
HLNC-8, 8/24/1976

10 55
HLNC-9, 8/24/1976

10 56
HLNC-10, 10/22/1976

10 57
HLNC-11, 12/18/1976

10 58
HLNC-12, 12/18/1976

10 59
HLNC-13, 12/20/1976

10 60
HLNC-14, 12/21/1976

10 61
HLNC-15, 12/22/1976

HIG series, 1977-1978 [subseries]:

10 62
HIG-1, 11/28/1977

10 63
HIG-2, 11/28/1977

10 64
HIG-3, 12/2/1977

10 65
HIG-4, 5/11/1978

10 66
HIG-5, 5/31/1978

10 67
HIG-NS-1, 1/11/1978

10 68
HIG-saline-2, 2/7/1978

10 69
HIG-saline-9, 7/12/1978

11 1
Nacl-01, 6/22/1978

11 2
Nacl-03, 7/10/1978

11 3
Nacl-04, 7/11/1978

11 4
Nacl-05, 7/12/1978

11 5
Nacl-3, 2/13/1978

11 6
Nacl-4, 2/22/1978

11 7
Nacl-5, 4/4/1978

11 8
Nacl-6, 4/18/1978

11 9
Nacl-7, 5/3/1978

11 10
Nacl-8, 5/10/1978

Hyperglycemia (LC) series, 1980-1987 [subseries]:

11 11
LC -- hyperglycemia 1, 1/15/1980

11 12
LC -- hyperglycemia 2, 1/28/1980

11 13
LC -- hyperglycemia 3, 2/1/1980

11 14
LC -- hyperglycemia 4, 12/3/980

11 15
LC -- hyperglycemia 5 -- Franz, Francesco, Jane, Esther, Sumio, 2/6/1980

11 16
LC -- hyperglycemia 6, 2/20/1980

11 17
LC -- hyperglycemia 7 -- Franz, Francesco, Jane, Esther, Sumio, 3/3/1980

11 18
LC -- hyperglycemia 8 -- Franz, Francesco, Sumio, Dr. Kennedy, Wolfgang, Jane Jehle, Esther, 3/12/1980

11 19
LC -- hyperglyc. 9 -- Franz, Francesco, Sumio, Jane, Dr. Kennedy, Wolfgang, Esther, 3/18/1980

11 20
LC -- hyperglycemia 10 -- Franz, Francesco, Sumio, Esther, Wolfgang, Dr. Kennedy, 3/27/1980

11 21
LC -- hyperglycemia 11 -- Franz, Francesco, Sumio, Dr. Kennedy, Wolfgang, Jane, 3/31/1980

11 22
LC -- hyperglycemia 12 -- Franz, Francesco, Sumio, Jane Jehle, Esther, 4/22/1980

11 23
LC -- hyperglycemia 13 -- Franz, Francesco, Sumio, Jane, Esther, 4/29/1980

11 24
LC -- hyperglycemia 14 -- Franz, Francesco, Sumio, Jane, Esther, 5/6/1980

11 25
LC -- hyperglycemia 15 -- Franz, Francesco, Sumio, Jane, Esther, 5/8/1980

11 26
LC -- hyperglycemia 16 -- Franz, Francesco, Jane, Esther, 5/13/1980

11 27
LC -- hyperglycemia 17 -- Franz, Francesco, Sumio, Jane, Esther, 5/19/1980

11 28
LC -- hyperglycemia 18 -- Franz, Francesco, Sumio, Jane, 5/21/1980

11 29
LC -- hyperglycemia 19 -- Franz, Francesco, Sumio, Jane, Esther, 5/23/1980

11 30
LC -- hyperglycemia 20 -- Franz, Francesco, Jane, Sumio, Esther, 5/30/1980

11 31
LC -- hyperglycemia 21 -- Franz, Francesco, Jane, Sumio, 5/30/1980

11 32
LC -- hyperglycemia 22 -- Franz, Francesco, Jane, 6/9/1980

11 33
LC -- hyperglycemia 23 -- Franz, Francesco, Jane, 6/11/1980

11 34
LC -- hyperglycemia 24 -- Franz, Francesco, Jane, 6/16/1980

11 35
LC -- hyperglycemia 25 -- Franz, Francesco, Jane, 6/19/1980

11 36
LC -- hyperglycemia 26 -- Franz, Francesco, Jane, 6/25/980

11 37
LC -- hyperglycemia 27 -- Franz, Francesco, Jane, Esther, 7/1/1980

11 38
LC -- hyperglycemia 28 -- Franz, Francesco, Sumio, Jane, Esther, 7/8/1980

11 39
LC -- hyperglycemia 29 -- Franz, Francesco, Jane, Esther, 7/10/1980

11 40
LC -- hyperglycemia 30 -- Franz, Francesco, Jane, Esther, 7/17/1980

11 41
LC -- hyperglycemia 31 -- Franz, Francesco, Jane, Esther, 7/21/1980

11 42
LC -- hyperglycemia 32 -- Franz, Francesco, Jane, Sumio, Esther, 7/24/1980

11 43
LC- hyperglycemia -- compiled data, 1980-1987

11 44
LC -- hyperglycemia -- error analyses, counting procedures, etc., 1980

11 45
LC table -- species, undated

Iodoantipyrine (IOD) series, 1976-1977 [subseries]:

11 46
Iodoantipyrine [ ]-CBF control 1, 4/1/1976

11 47
Iodoantipyrine [ ]-CBF control 2, 4/2/1976

11 48
Iodoantipyrine [ ]-CBF control 3, 4/3/1976

11 49
14c -- iodoantiyprine, [ ]-CBF control 4, 4/6/1976

11 50
14c -- iodoantipyrine, [ ]-CBF control 5, 4/6/1976

11 51
14c -- iodoantipyrine -- [ ]-CBF control 6, 4/7/1976

11 52
Chromatography for 14c -- iodoantipyrine, 7/7/1976

11 53
Chromatography of iodoantipyrin experiment -- by J. D. Brown, 1976

11 54
Dissolve of 14c -- iodoantipyrine into dioxane phosphov., undated

11 55
IOD-C-7, 14c iodoantiyprine normal cat, 8/19/1976

11 56
IOD-C-8, 1/6/1977

11 57
Iodoantipyrine cat normal control 1, 5/6/1976

11 58
Iodoantipyrine cat normal control 2, 5/14/1976

11 59
Iodoantipyrine normal CBF cat 3, 5/20/1976

11 60
Iodoantipyrine normal control 4, 5/27/1976

11 61
Iodoantipyrine cat normal control 5, 6/4/1976

11 62
Iodoantipyrine cat normal control 6, 6/11/1976

11 63
Iodoantipyrine cat study summary, undated

11 64
Iodoantipyrine solubility property, undated

11 65
Iodoantipyrine study summary, undated

11 66
Iodoantipyrine, radiochromatogram -- CFG 1265, 1976

11 67
Iodoantipyrine, radiochromatogram -- CFQ 1460, 1976

IP series, 1993 [subseries]:

11 68
IPBF 1-4, 1993

11 69
IPBF 5-8, 1993

11 70
IPBF 9-12, 1993

11 71
IPBF 13-16, 1993

11 72
IPBF 17-20, 1993

12 1
IPBF 21-24, 1993

12 2
IPBF 25-28, 1994

12 3
IPBF 29-32, 1994

12 4
IPDG 2 L-NAME, 1993

12 5
IPDG 3 L-NAME, 1993

12 6
IPDG 4 saline, 1993

12 7
IPDG 5, saline, 1993

12 8
IPDG 6, L-NAME, 1993

12 9
IPDG 7, L-NAME, 1993

12 10
IPDG 8, saline, 1993

12 11
IPDG 9, saline, 1993

12 12
IPDG 10, L-NAME, 1993

12 13
IPDG 11, saline, 1993

12 14
IPDG 12, saline, 1993

12 15
IPDG 13, L-NAME, 1993

12 16
IPDG 14, saline, 1993

12 17
IPDG 15, saline, 1993

12 18
IPDG 16, L-NAME, 1993

12 19
IPDG 17, saline, 1993

12 20
IPDG 18, saline, 1993

KSA series, 1975-1976 [subseries]:

12 21
Antipyrine chromatography, KSA 101 and 102 (plasma), 1975

12 22
Series KSA-0: antipyrine for BDBF pulse inf. for laplace transf., undated

12 23
KSA-101, CBF (K-s) antipyrine, sq. wave 60', 1975

12 24
KSA-102, CBF (K-S) antipyrine, sq. wave 35', 1975

12 25
KSA-103, CBF (K-S) antipyrine, pulse-50 uc-60', 1975

12 26
KSA-103: chromatography on plasma and brain, 1976

12 27
KSA-104 and 105, in brain and plasma, 1976

12 28
KSA-104, discarded, 1976

12 29
KSA-105, discarded, 1976

12 30
KSA-106, discarded, 1976

12 31
KSA-107, discarded, 1976

12 32
KSA-108, discarded, undated

12 33
KSA-109, discarded, 1976

12 34
KSA-110, discarded, 1976

12 35
KSA-114, discarded, 1976

12 35
KSA-118, discarded, 1976

12 37
KSA-119, discarded, 1976

12 38
KSA-120, discarded, 1976

12 39
KSA-124, undated

12 40
KSA-127, discarded, 1976

12 41
KSA-128, discarded, 1977

12 42
KSA-129, normal control (immobilization), 1977

12 43
KSA-131, 5% CO2, CBF, 1977

12 44
KSA-132, normal control, 1977

12 45
KSM-101, methylglucose as tracer for GCBF, 1975

12 46
KSM-102, methylglucose as tracer for GCBF, 1975

12 47
Series KSH: hippuric acid as tracer for GCBF, 1976

12 48
Series KSM1 -- KSM3: methylglucose as tracer for GCBF, 1975

Lidocaine (Lido) series, 1978-1979 [subseries]:

12 49
Lido-1, control, 7/24/1978

12 50
Lido-1', 7/24/1978

12 51
Lido-2, 8/3/1978

12 52
Lido-3, 2 lidocaine, 8/10/1978

12 53
Lido-4, 1 lidocaine, 8/10/1978

12 54
Lido-5, saline control, 1/11/1979

12 55
Lido-5', no seizure history, 1/11/1979

12 56
Lido-6, saline, 1/12/1979

12 57
Lido-6', lidocaine, 1/12/1979

12 58
Lido-7, saline, 1/19/1979

12 59
Lido-7', lidocaine, 1/19/1979

12 60
Lido-8, saline, 1/25/1979

12 61
Lido-8', lidocaine, 1/25/1979

12 62
Lido-9, saline, 1/26/1979

12 63
Lido-9' (experimental animal), 1/26/1979

12 64
Lido-10, saline control, 2/1/1979

12 65
Lido-10', lidocaine, 2/1/1979

12 66
Lido-11, saline control, 2/2/1979

12 67
Lido-11', lidocaine, 2/2/1979

12 68
Lido-12, saline, 2/15/1979

12 69
Lido-12', lidocaine, 2/15/1979

12 70
Lido-13, saline, 2/16/1979

12 71
Lido-13', lidocaine, 2/16/1979

12 72
Lidocaine summary, 1979

Glucose Utilization (LCGU) series, 1977-1987 [subseries]:

12 73
Cerebral structure w/ signif. changes in LCGU at higher doses of D-LSD, 1976-1977

12 74
Effects of LSD on LCGU in individual structures as a function of dose, undated

12 75
Experiments -- hyperglycemia R.C. average, 1984

12 76
Free moving immobilization on LCGU and LCBF, 1978

12 77
Glucose / LCGU : from 0' -- 120', undated

12 78
Hyperglycemia LCGU experiments -- excluded and misc., 1980-1982

13 1
Hyperglycemia LCGU experiments -- excluded and misc. [cont'd.], 1980-1982

13 2
Hyperglycemia LCGU experiments -- used and tables, 1982

13 3
Hyperglycemia LCGU experiments 450, 1984

13 4
Hyperglycemia LCGU experiments 450 (programming changes), 1984

13 5
Hyperglycemia LCGU experiments 550A, 1984

13 6
Hyperglycemia, 2DG, 450's, 1984

13 7
L.C.G.U. (pulse exp.) parameters: new 3 rate constants, 1986

13 8
L.C.G.U. (pulse experiments) from Dr. Shinohara's data representative structures, 1977

13 9
LCGU -- pulse experiments -- LC=0.483 -- parameters: new 3 rate constants, 1986

13 10
LCGU -- sandro, undated

13 11
LCGU -- taro, undated

13 12
LCGU (pulse experiments) -- 5 rate constants (K4*=0.002), 1986

13 13
LCGU (pulse experiments) Shinohara series -- graphs -- representative structures, 1977

13 14
LCGU (pulse) parameters 5 rate constants (K4*=0.0014), 1986

13 15
LCGU (square exp.) parameters 5 rate constants (K4*=0.001), 1986

13 16
LCGU (square wave experiments) graphs, undated

13 17
LCGU (square wave experiments) gray structures, undated

13 18
LCGU (square wave experiments) white structures, undated

13 19
LCGU hyperglycemia experiments -- Franz, Francesco, 1980

13 20
LCGU pulse experiments -- 5 rate constants (K4*=0.001), 1986

13 21-23
Local Cerebral Glucose Utilization, 1987

13 24
Shinohara pulse data -- LCGU w/5 -- H model -- K4=.002, K5=.05, 1986

13 25
Spinal cord (sleep) -- LCGU, undated

13 26
Summary of LCGU (pulse) with original rate constants, 1987

13 27
Summary of local LCGU -- square wave exp., undated

13 28
Table for LCGU value, undated

13 29
The effect of NMA on LCGU in the rat, undated

13 30
Weighted average LCGU -- pulse experiments, undated

LS series, 1977-1979 [subseries]:

14 1
LS-11, general, 8/29/1978

14 2
LS-II-1, 1977

14 3
LS-II-2, 11/8/1977

14 4
LS-II-3, 11/8/1977

14 5
LS-II-4, 11/8/1977

14 6
LS-II-5, 11/10/1977

14 7
LS-II-6, 11/11/1977

14 8
LS-II-7, 11/11/1977

14 9
LS-II-8, 12/9/1977

14 10
LS-II-9, 12/9/1977

14 11
LS-II-10, 12/9/1977

14 12
LS-II-11,12,13, 2/24/1978

14 13
LS-II-14,15,16, 4/3/1978

14 14
LS-II-17, 4/7/1978

14 15
LSB-2, 1979

14 16
LSB-3, 1977

14 17
LSB-4, 1977

14 18
LSB-5, 1977

14 19
LSB6-10, 1977

MG series, 1973, 1988-1989 [subseries]:

14 20
Extracting rat brain containing 3H-MG with hexane and chloroform by H. Nakanishi, 1988-1989

14 21
HIGH std.-2, 14c-MG, 10/2/1978

14 22
HIGH-STD-3, 14c-MG, 10/2/1978

14 23
MG and hypothalam atlas [computer disk], undated

14 24
MG series '73, 1973

14 25
MG-1, 5' cont., 1973

14 26
MG-2, 10' -- cont., 1973

14 27
MG-3, 20' -- cont., 1973

14 28
MG-4, 30' -- cont., 1973

14 29
MG-5 (C14), 2 hrs., 1973

14 30
MG-6 (C14), 1 min., 1973

14 31
MG 7 (C14), 15' cont., 1973

14 32
MG-8 (C14), 60' cont., 1973

14 33
MG-9, 45' cont., 1973

14 34
MG-10 (C14), 4' -- cont., 1973

14 35
MG-11 (C14), 45' -- cont., 1973

14 36
MG-12 (C14), 40' -- bol. C.S.F., 1973

14 37
MG-13 (C14), 4' -- cont., 1973

14 38
MG-14 (C14), 50' -- bol. C.S.F., 1973

14 39
MG-15, 75' -- bol. C.S.F., 1973

14 40
MG-16, 120' -- bol. C.S.F., 1973

14 41
MG-17, 60' -- bol. C.S.F., 1973

14 42
MG-18, 240' -- bol. C.S.F., 1973

14 43
MG-101 and 102, 30' -- B -- 51 u., 1973

14 44
MG-103 and 104, 45' -- B -- 76 uc., 1973

14 45
MG-105, B -- 120' -- 51 uc., 1973

14 46
MG-106 and 107, B -- 45' -- 51 uc., 1973

14 47
MG-108, B -- 120' -- 51 uc., 1973

14 48
MG-109 and 110, B -- 60 -- 51 uc., 1973

14 49
MG-111 and 112, B -- 75' -- 51 uc., 1973

14 50
MG-113 and 114, B -- 90' -- 51 uc., 1973

MSG series, 1978 [subseries]:

14 51
MSG-01, 6/22/1978

14 52
MSG-03, 7/10/1978

14 53
MSG-04, 7/11/1978

14 54
MSG-05, 7/11/1978

14 55
MSG-06, 7/12/1978

14 56
MSG-07 (experiment stop), 7/12/1978

14 57
MSG-1, 1/11/1978

14 58
MSG-2, 2/7/1978

14 59
MSG-3, 2/13/1978

14 60
MSG-4, 2/25/1978

14 61
MSG-5, 4/4/1978

14 62
MSG-6, 4/18/1978

14 63
MSG-7, 5/3/1978

Radioactive isotope studies [subseries]:

152 7
Correspondence - miscellaneous, [1951-1952]

152 8
Radioactivity work, [c.1950]

152 9
Phosphorous 32, [c.1952]

152 10
Radioactive iodine - I131, [c.1952]

152 11
Radioactive Krypton, [1951]

152 12
Krypton study, [1952]

152 13
[Investigation of effectiveness of circulation and radioactive isotope tracers], [c.1950s]

Na24 series, 1956-1957 [subseries]:

152 14
[Radioactive Sodium [Na24] USPHS study], [1951-1953]

152 15
Na24 clearance with perfusion in dogs with blood flow determinations, [1953]

14 64
[patient name redacted] -- LBF -- Na24, 1956

14 65
[patient name redacted] -- LBF -- Na24, 1956

14 66
[patient name redacted] -- LBF -- Na24, 1957

14 67
[patient name redacted] -- LBF -- Na24, 1956

14 68
[patient name redacted] -- LBF -- Na24, 1956

14 69
[patient name redacted] -- LBF -- Na24, 1956

14 70
[patient name redacted] -- LBF -- Na24, 1957

14 71
[patient name redacted] -- LBF -- Na24, 1956

14 72
[patient name redacted], 1957

14 73
[patient name redacted] -- LBF -- Na24, 1957

14 74
[patient name redacted] -- LBF -- Na24, 1957

14 75
[patient name redacted] -- LBF -- Na24, 1956

14 76
[patient name redacted] -- LBF -- Na24, 1956

14 77
[patient name redacted] -- LBF -- Na24, 1957

14 78
NA24, 1954

14 79
Na24 -- leg blood flow studies, 1956

14 80
Na24 -- leg blood flow studies -- book 2, 1957

14 81
[patient name redacted] -- LBF -- Na24, 1957

14 82
[patient name redacted] -- LBF -- Na24, 1957

14 83
[patient name redacted] -- LBF -- Na24, 1957

14 84
[patient name redacted] -- LBF -- Na24, 1956

14 85
[patient name redacted] -- LBF -- Na24, 1956

14 86
[patient name redacted] -- LBF -- Na24, 1956

14 87
[patient name redacted] -- LBF -- Na24, 1956

14 88
[patient name redacted] -- LBF -- Na24, 1956

Rolled paper graph readouts

134
[patient name redacted], muscular dystrophy, control and exercised, 1/24/1957 [RESTRICTED PHI]

134
[patient name redacted], 6/9/1957 [RESTRICTED PHI]

134
[patient name redacted], LBF, 5/15/1957 [RESTRICTED PHI]

134
[patient name redacted], muscular dystrophy, control and exercised, 11/1/1956 [RESTRICTED PHI]

134
[patient name redacted], myotonia atrophy, LBF with exercise, 5/16/1957 [RESTRICTED PHI]

134
[patient name redacted], 10/10/1956 [RESTRICTED PHI]

134
[patient name redacted], normal control, control priscoline, 3/7/1957 [RESTRICTED PHI]

134
[patient name redacted], LBF, muscular dystrophy with exercise, 1/20/1957 [RESTRICTED PHI]

134
[patient name redacted], leg blood flow, 10/11/1956 [RESTRICTED PHI]

134
[patient name redacted], leg blood flow, 10/31/1956 [RESTRICTED PHI]

134
[patient name redacted], leg blood flow, 2/21/1957 [RESTRICTED PHI]

134
[patient name redacted], normal, control Arlidin, 3/21/1957 [RESTRICTED PHI]

134
[patient name redacted], normal control-LBF, Na24 with Arlidin, 2/1957 [RESTRICTED PHI]

134
[patient name redacted], LBF -- normal control, with priscoline, 1, 4, leg counts, Na24, 5/14/1957 [RESTRICTED PHI]

134
[patient name redacted], normal control -- LBF with Na24, Priscoline, 50mg, I.A., 12/12/1956 [RESTRICTED PHI]

134
[patient name redacted], muscular dystrophy, 1-control, 2-exercise, 1/23/1957 [RESTRICTED PHI]

134
[patient name redacted], LBF leg counts, Na24, normal control, with Arlidin, 10mg. I.A., 10/11/1956 [RESTRICTED PHI]

134
[patient name redacted], LBF with Na24, normal control with priscoline, 50mg, I.A., 3/7/1957 [RESTRICTED PHI]

134
[patient name redacted], leg blood flow, muscular dystropy, control and exercise, 11/1/1956 [RESTRICTED PHI]

134
[patient name redacted], leg counts of Na24 at 100 [cm], 10/10/1956 [RESTRICTED PHI]

134
[patient name redacted], Arlidin, 3/21/1957 [RESTRICTED PHI]

134
[patient name redacted], myotonia dystrophica, Na24 leg blood flow with exercise, 5/16/1957 [RESTRICTED PHI]

135
[patient name redacted] (paranoid schizophrenia), leg blood flow control and exercise, 12/13/1957 [RESTRICTED PHI]

135
[patient name redacted], muscular dystrophy with exercise, Na24, leg blood flow, 2/20/1957 [RESTRICTED PHI]

135
[patient name redacted], LBF with Na24, undated [RESTRICTED PHI]

135
[patient name redacted], muscular dystrophy with exercise, Na24 leg blood flow, 1/24/1957 [RESTRICTED PHI]

135
[patient name redacted], muscular dystrophy, LBF, Na24 with exercise, 1/24/1957 [RESTRICTED PHI]

135
[patient name redacted], muscular dystrophy, LBF with Na24, exercise, 9/20/1956 [RESTRICTED PHI]

135
[patient name redacted], normal control, Arlidin, 10 mg, I.A., 6/19/1957 [RESTRICTED PHI]

135
[patient name redacted], s, LBF with Na24, Arlidin, 10 mg. I.A., 10/31/1956 [RESTRICTED PHI]

135
[patient name redacted], 12/12/1956 [RESTRICTED PHI]

135
[patient name redacted], leg blood flow, 1-control, 2-Arlidin, 10/31/1956 [RESTRICTED PHI]

135
[patient name redacted], 6/21/1956 [RESTRICTED PHI]

135
[patient name redacted], LBF, Na24 with exercise, schizo., 12/13/21956 [RESTRICTED PHI]

135
[patient name redacted], LBF with Na24, 7/11/1956 [RESTRICTED PHI]

135
[patient name redacted], myotonia dystrophica, LBF with Na24, exercise, 5/16/1957 [RESTRICTED PHI]

135
[patient name redacted], LBF with Na24, normal control, with Arlidin, 10 mg, I.A., 10/11/1956 [RESTRICTED PHI]

135
[patient name redacted], LBF with Na24, dystrophy, with exercise, 11/1/1956 [RESTRICTED PHI]

135
[patient name redacted], LBF with Na24, normal control, Arlidin, 10 mg, I.A., 3/21/1957 [RESTRICTED PHI]

135
[patient name redacted], LBF with Na24, normal control with Priscoline, 50 mg, I.A., 12/12/1956 [RESTRICTED PHI]

135
[patient name redacted], normal control, leg blood flow -- Na24, Arlidin, 10 mg, I.A., 2/21/1957 [RESTRICTED PHI]

135
[patient name redacted], LBF with Na24, Priscoline, I.A., 9/19/1956 [RESTRICTED PHI]

135
[patient name redacted], normal control, LBF with Na24, Arlidin, 10 mg, I.A., 6/19/1957 [RESTRICTED PHI]

135
[patient name redacted], LBF with Na24, normal control, Priscoline, 50 mg., I.A., 3/7/1957 [RESTRICTED PHI]

135
[patient name redacted], dystrophy, LBF with Na24 and exercise, 2/20/1957 [RESTRICTED PHI]

135
[patient name redacted], LBF with Na24 and exercise, 10/10/1956 [RESTRICTED PHI]

135
[patient name redacted], LBF with Na24, 6/6/1956 [RESTRICTED PHI]

135
[patient name redacted], 7/12/1956 [RESTRICTED PHI]

135
[patient name redacted], LBF with Na24, normal control, Priscoline, 50 mg., I.A., 8/1/1956 [RESTRICTED PHI]

135
[patient name redacted], muscular dystrophy with exercise, 1/23/1957 [RESTRICTED PHI]

135
[patient name redacted], muscular dystrophy, LBF with Na24, 1/23/1957 [RESTRICTED PHI]

Lab notebooks

154 1-6
Books 1-6, 1952-1953 [RESTRICTED PHI]

153 1-4
Na24 clearance perfusion, book 1-2 [dogs], 1952-1953

New born monkey (NBM) series, 1970-1979, 1983-1989 [subseries]:

14 89
Assay of monkey blood, 1978

14 90
LCM 6, 9/30/1976

14 91
LCM-7, 10/14/1976

14 92
LCM 9, 11/18/1976

14 93
Monkey K-732-1, 1971

14 94
Monkey K739-2, 1971

14 95
Monkey lumped constant study, no. 1 [photograph], 1976

14 96
Monkey lumped constant study, no. 2, 1976

14 97
Monkey lumped constant study, no 3, 1976

14 98
Monkey lumped constant study, no 4, 1976

14 99
Monkey lumped constant study, no. 5, 1976

14 100
Monkey-control -- misc., 1985-1989

14 101
NBM-101, tarsoraphy at. 2 days, 1976-1985

14 102
NBM-2, rt. eye patched (LCGU), 11/24/1978

14 103
NBM-3, LCGU 3, 1976-1977

14 104
NBM-4 [diskette], 1983

14 105
NBM4, new born monkey, LCGU-control, 1976

14 106
NBM-5 (LCGU control), 3/15/1976

15 1
NBM-6, LCGU, 3/22/1976

15 2
NBM7 (new born monkey control), 1976

15 3
NBM-8, LCGU-30', r. eye patched, 1978

15 4
Newborn monkey, LCGU control (NBM1), 1976

15 5
PEN. SEIZ.: adult monk. controls + experimentals, 1970

15 6
PEN. SEIZ.: newborn monk. experimentals, 1970

15 7
PEN. SEIZ: newborn monkeys controls, 1970

15 8
Pen-C, 1, 1975

15 9
Series S.M.: laplace transform, 2-DG conscious monkeys, 1976

15 10
Statist. -- new born monkey, 1979

15 11
Stimulated monkey -- summary tables and graphs, undated

PCP series, 1986-1987 [subseries]:

15 12
PCP-1 -- 10 mg/kg, 1986

15 13
PCP -- 2 Saline 0.36, 1986

15 14
PCP -- 3 1 mg/kg, 1988

15 15
PCP -- 4 N. Saline, 1986

15 16
PCP -- 5 0.3/kg, 1986

15 17
PCP -- 6 3mg/kg, 1986

15 18
PCP -- 7 1mg/kg, 1987

15 19
PCP -- 8 0.1mg/kg, 1987

15 20
PCP -- 9 10mg/kg, 1987

15 21
PCP -- 10 N.S., 1988

15 22
PCP -- 11 3mg/kg, 1986

15 23
PCP -- 12 0.3mg/kg, 1986

15 24
PCP -- 13 1mg/kg, 1987

15 25
PCP -- 14 0.1mg/kg, 1987

15 26
PCP -- 15 3.0mg/kg, 1987

15 27
PCP -- 16 N.S., 1987

15 28
PCP -- 17 0.3mg/kg, 1986

15 29
PCP -- 18 10mg/kg, 1986

15 30
PCP -- 19 N.S., 1986

15 31
PCP -- 20 0.1mg/kg, 1987

15 32
PCP -- 21 0.3/kg, 1987

15 33
PCP 21-2, 1987

15 34
PCP -- 22 3mg/kg, 1987

15 35
PCP -- 23 10mg/kg, 1987

15 36
PCP -- 24 N.S., 1987

15 37
PCP -- 25 1mg/kg, 1986

15 38
PCP -- 26 10mg/kg, 1987

15 39
PCP 27 0.3mg/kg, 1987

15 40
PCP 28 0.1mg/kg, 1988

15 41
PCP Data, 1987

15 42
PCP Raw Data, 1986

PT series, 1949-1950, 1979-1987 [subseries]:

15 43
PT series -- scp*(t)/cp* -- scp*dt/T, 1949-1950

15 44
Pulse 2DG experiments -- PT series -- Ken Mori StCp*(t)dt, 1986

15 45
PT series plus experiments -- physiological conditions, 1987

15 46
Summary PT series -- stretch time etc., pulse exp. mori, 1979-1986

15 47
PT-2 -- 60 min., July 25, 1986

15 48
PT-6 -- 35 min., July 26, 1986

15 49
PT-7 -- 120 min., Aug. 4, 1986

15 50
PT-8 -- 60 min., Aug. 4, 1986

15 51
PT-9 -- 25 min., Aug. 4, 1986

15 52
PT-10 -- 90 min. exp., Aug. 5, 1986

15 53
PT-11 -- 35 min. exp., Aug. 5, 1986

15 54
PT-12 -- 45 min. exp., Aug. 5, 1986

15 55
PT-13 -- 120 min. exp., Aug. 1986

15 56
PT-14 -- 60 min., Aug. 6, 1986

15 57
PT-15 -- 25 min., Aug. 6, 1986

15 58
PT-16 -- 90 min. exp., Aug. 7, 1986

15 59
PT-17 -- 45 min. exp., Aug. 7, 1986

15 60
PT-18 -- 35 min. exp., Aug. 7, 1986

15 61
PT-20 -- 60 min. exp., Aug. 8, 1986

15 62
PT-21, Aug. 8, 1986

15 63
PT 22 -- 120 min. exp., Aug. 11, 1986

15 64
PT 23 -- 90 min. exp., Aug. 11, 1986

15 65
PT 24 -- 4-5 min. exp., Aug. 11, 1986

15 66
PT-25 -- 120 min. exp., Aug. 13, 1986

15 67
PT-26 -- 90 min. exp., Aug. 13, 1986

15 68
PT-27 -- 35 m in. exp., Aug. 13, 1986

15 69
PT-28 -- 45 min. exp., Aug. 14, 1986

15 70
PT-29 -- 25 min. exp., Aug. 14, 1986

15 71
PT-31 -- 25 min., Nov. 17, 1986

15 72
PT-32 -- 90 min., Nov. 18, 1986

15 73
PT-33 -- 25 min., Nov. 18, 1986

15 74
PT-34- 45 min. exp., Nov. 24, 1986

15 75
PT-35 -- 35 min. exp., Nov. 24, 1986

15 76
PT-36 -- 35 min., Nov. 24, 1986

15 77
PT-37 -- 45 min., Nov. 25, 1986

15 78
PT-38 -- 35 min., Nov. 25, 1986

15 79
PT-39 -- 45 min. exp., Nov. 26, 1986

15 80
PT-40 -- 25 min. exp., Nov. 26, 1986

15 81
PT-41 -- 25 min. exp., Nov. 26, 1986

15 82
PT-42 -- 60 min. exp., Nov. 28, 1986

15 83
PT-43 -- 35 min. exp., Nov. 28, 1986

15 84
PT-44 -- 45 min. exp., Nov. 28, 1986

15 85
PT series -- parameters with new three rate constants -- K1*=0.232, K2*=0.240, K3*=0.061, 1985-1986

PX series, 1978 [subseries]:

15 86
PX-0 (.42 mg/kg), 5/3/1978

15 87
PX-01 (.42 mg/kg), 8/21/1978

15 88
PX-02 (.42 mg/kg), 8/21/1978

15 89
PX-1 (21 mg/kg, 8.6 mg pulse), 2/8/1978

15 90
PX-2 (7.8 mg pulse), 2/29/1978

15 91
PX-3 (8.5 mg pulse), 2/29/1978

15 92
PX-4 (21 mg/kg, 8.2 mg pulse), 3/15/1978

16 1
PX-5 (4.2 mg/kg), 3/30/1978

16 2
PX-6 (4.2 mg/kg), 3/30/1978

16 3
PX-7 (4.2 mg/kg), 4/5/1978

16 4
PX-8 (4.2 mg/kg), 4/12/1978

16 5
PX-9 (42 mg/kg), 4/12/1978

16 6
Px-10, 4/19/1978

16 7
Px-11, 4/19/1978

16 8
PX-12 (4.2 mg/kg), 4/27/1978

16 9
PX-13 (4.2 mg/kg), 5/9/1978

16 10
PX-14 (42 mg/kg), 5/9/1978

16 11
PX-15 (4.2 mg/kg), 8/21/1978

16 12
PX-16 (21 mg/kg), 8/21/1978

16 13
PX-17 (42 mg/kg), 8/25/1978

16 14
PX-18 (9 mg/kg), 12/10/1978

16 15
PX-19 (9 mg/kg), 12/10/1978

16 16
PX-20 (9 mg/kg), 12/11/1978

16 17
PX-21 (9 mg/kg), 12/22/1978

16 18
PX-22 (9 mg/kg), 12/13/1978

SM series, 1973-1985 [subseries]:

16 19
SM-1, B-45'-320 ul -- rt. eye covered and wurtz, 1975

16 20
Series SM-2: unilateral patching, 1973

16 21
SM-2A, B'-45'-100 uc, both eyes opened, 1973-1978

16 22
SM-3, P-45'-250 uc. (rt. eye patched), 1973-1975

16 23
SM-3A, visual: rt. eye removed, P-45'-250 uc, 1973-1975

16 24
SM-4A, both eyes opened and wurtz pattern -- P-45'-300 uc, 1973-1975

16 25
Series SM-5: both eyes patched, 1975

16 26
SM-6, 45'-300 mc -- both eyes patched, 1974-1975

16 27
Series SM-7: eyes intact + stimulation, 1974

16 28
SM-8A, 1974-1977

16 29
Series SM-9A: eyes intact + stimulation, 1975-1977

16 30
SM-10, both eyes intact and wurtz pattern, 1974-1975

16 31
SM-11, 1978

16 32
SM-11, both eyes intact and wurtz, pattern, 1974-1977

16 33
Series SM-12: eyes intact + stimulation, 1974-1977

16 34
SM-13, left eye removed and wurtz, 1974

16 35
SM-14, rt. eye removed and ambient light, 5/1/1975

16 36
Series SM-15: unilateral enucleation, 1975

16 37
Series SM-16: unilateral enucleation, 1975

16 38
SM-17, left eye patched and wurtz, 8/7/1975

16 39
Series SM-18: unilateral enucleation, undated

16 40
SM-19, left eye patched and wurtz, 11/6/1975

16 41
SM-20, left eye patched and wurtz, 11/20/1975

16 42
SM-21, rt. eye patched and wurtz [photograph], 12/23/1975

16 43
SM-22, left eye removed and wurtz, 12/23/1975

16 44
SM-23, both eyes open, 1/23/1976

16 45
SM-24, both eyes patched, 2/5/1976

16 46
SM-25, 2/19 -- rt. eye patched and wurtz, 2/19/1976

16 47
SM-26, 3/19 -- rt. eye patched and wurtz, 3/19/1976

16 48
SM-27, 5/28 -- both eyes opened and wurtz, 5/28/1976

16 49
SM-28, 8/2/1976

16 50
SM-29, 11/4/1976

16 51
SM-30, 12/9/1976

17 1
SM-31, 1976-1985

17 2
SM-32, 1/18/1977

17 3
SM33 and SM24, densitometry, undated

17 4
SM-33, both eyes occluded, 8/4/1977

17 5
SSM-1/SSM-3, undated

17 6
SSM-2, 1979

17 7
SSM-2 [diskette], 4/7/1977

17 8
SSM-4 (rt. optic tract sectioned), 1977

17 9
SSM-4 [8 computer disk]", 1979

SR series, 1973-1974 [subseries]:

17 10
Series SR-1: visual alterations, 1973

17 11
Series SR-1A: visual alterations, 1973

17 12
Series SR-2: visual alterations, 1973

17 13
Series SR-2A: visual alterations, 1973

17 14
Series SR-3: visual alterations, 1973

17 15
Series SR-3A: visual alterations, 1973

17 16
SR-3B (l. eye remove), 1973

17 17
SR-4-I (r-eye remove), 1973

17 18
SR-4-II (l-eye remove), 1973

17 19
S.R.-5, (left eye patched, TOT -- darkness, I.P.S.), 1973

17 20
Series SSR: sciatic nerve stimulation, 1974

Thyroxine series, 1954-1975 [subseries]:

17 21
Reprints -- thyroxine, 1956

17 22
Summaries of thyroxine mitochondrial factor studies, 1964-1965

17 23
Summaries thyroxine effects on pyridine nucleotides, 1975

17 24
T4 effect on mitochondrial NAD+, 1970

17 25
Thyroxine -- illustrations [photographs, negatives], undated

17 26
Thyroxine -- protein synthesis, 1955-1965

17 27
Thyroxine -- protein synthesis in vivo, 1963-1964

136 8-9
Thyroxine -- Protein Synthesis -- Index, undated

17 28
Thyroxine -- uptake by brain, 1954-1955

17 29
Thyroxine analogues [photographs, negatives], 1963

17 30
Thyroxine effects on NAD+, 1974

17 31
Thyroxine effects on pyridine nucleotides -- amino-chance scans [folder 1 of 3], 1974-1975

17 32
Thyroxine effects on pyridine nucleotides -- amino-chance scans [folder 2 of 3], 1974-1975

17 33
Thyroxine effects on pyridine nucleotides -- amino-chance scans [folder 3 of 3], 1974-1975

17 34
Thyroxine effects on pyridine nucleotides, 1974

17 35
Thyroxine experiments, 1964

18 1
Thyroxine experiments -- book 2, 1957-1958

18 2
Thyroxine experiments -- book 3, 1958

18 3
Thyroxine factor [negatives], undated

18 4
Thyroxine iodine studies, 1954-1955

18 5
Thyroxine mechanism -- tables and illus. [photographs, negatives], undated

136 10
Thyroxine-Mitochondrial Factor -- Index [includes slides], undated

18 6
Thyroxine project -- charts and slides [photographs, negatives], undated

18 7
Thyroxine project -- charts and slides [photographs, negatives], undated

18 8
Thyroxine solutions, 1959-1964

18 9
Thyroxine solutions II, 1965-1972

18 10-12
Thyroxine-mitochondrial factor -- preparations and properties -- book 1, 1966-1968

Whisker barrel (WB) series, 1991-1993 [subseries]:

18 13
WB i.v. study, statistics, 1992

18 14
01 whisker barrel series: control, 1991

18 15
WB-02 experiment NMA 30 mg/kg, 1991

18 16
WB-03 control, 1991

18 17
WB-04, control, 1991

18 18
WB-05, experiment NMA 30 mg/kg, 1991

18 19
WB-06, exp. normal saline 1.1 ml, 1991

18 20
WB-07, exp. NMA 30 mg/kg, 1991

18 21
WB-08, exp. NMA 30 mg/kg, 1991-1992

18 22
WB-09, control, 1991

18 23
WB-09, control, 1991

18 24
WB-11, exp. NMA 30 mg/kg, 1991

18 25
WB-12, NMA 100 mg/kg, 1991

18 26
WB-13, NMA 100 mg/kg, 1991

18 27
WB-14, NMA 100 mg/kg, 1991

18 28
WB-15, NMA 100 mg/kg i.v., 1991

18 29
WB-16, control (saline + no stimulation), 1991

18 30
WB-17, NMA 30 mg/kg i.v., 1991-1992

18 31
WB-18, control, 1991-1992

18 32
WB-19, saline i.v. + no stimulation, 1991

18 33
WB-20, control, 1991

18 34
WB-21, control, 1991-1992

18 35
WB-22, methyl ester, 1992

18 36
WB-22, methyl ester 30 mg/kg i.v., 1992

18 37
WB-24, control, 1992

18 38
WB-25, NAME, 1992

18 39
WB-26, control (saline i.v. and no stimulation), 1992

18 40
WB-27, NAME, 1992

18 41
WB-28, control, 1992

18 42
WB-29, control, 1992

18 43
WB-30, nitro-L-arginine methylester, 1992

18 44
WB-31, control, 1992

18 45
WB-32, nitro-L-arginine methylester, 1992

18 46
WB-33, NAME, 1992

18 47
WB-34, control, 1992

18 48
WB-35, nitro-L-arginine methylester, 1992

18 49
WB-36, nitro, fast infusion, 1992

18 50
WB-37, control, 1992

18 51
WB-38, nitro-L-arginine M.E., 600 ug/rat, 1992

18 52
WB-39, control (DIR), 1992

18 53
WB-40, nitro (direct), 600 ug/rat, 1992

18 54
WB-41, control (direct), 1992

18 55
WB-42, nitro-L-arginine (direct), 1992

18 56
WB-43, nitro-L-arginine, 600 ug/rat, 1992

18 57
WB-44, control, 1992

18 58
WB-45, nitro-L-arginine, 600 ug/rat, 1992

18 59
WB-46, nitro-L-arginine, 600 ug/rat, 1992

18 60
WB-47, control, 1992

18 61
WB-48, control, 1992

18 62
WB-49, nitro-L-arginine, 600 ug/rat, 1992

18 63
WB-50, control, 1992

18 64
WB-51, nitro-L-arginine, 600 ug/rat, 1992

18 65
WB-52and53, 3H-nitro-L-arginine and intracisternal infusion, 1993

18 66
WB-54, chronic and NAME, 1993

18 67
WB-55, chronic i.p. and NAME, 1993

18 68
WB-56, chronic ad of NAME, 1993

18 69
WB-57, chronic i.p., 1993

18 70
WB-58, chronic i.p., 1993

18 71
WB-59, chronic i.p., 1993

18 72
WB-60, L-NAME chronic i.p., 1993

18 73
WB-61, chronic i.p., 1993

18 74
WB-62, chronic i.p., 1993

18 75
WB-63, saline chronic i.p., 1993

18 76
WB-64, saline chronic i.p., 1993

18 77
WB-65, saline chronic i.p., 1993

18 78
WB-66, saline chronic i.p., 1993

19 1
WB-cisternal infusion, 1992

19 2
WBDG -- DG parity check, 1992

19 3
WBDG-1, 1992

19 4
WBDG-2, 1991-1992

19 5
WBDG-3, 1991-1992

19 6
WBDG-4, 1992

19 7
WBDG-5, 1992

19 8
WBDG-6, 1992

19 9
WBDG-7, 1992

19 10
WBDG-8, 1992-1993

YOH series, 1978 [subseries]:

19 11
YOH-1 (.25 mg/kg/min.), 4/5/1978

19 12
YOH-3 (.25 mg/kg/min.), 7/10/1978

19 13
YOH-4 (.25 mg/kg/min.), 7/10/1978

19 14
YOH-5 (.1 mg/kg/min.), 7/11/1978

19 15
YOH-6 (.25 mg/kg/min.), 7/11/1978

19 16
YOH-7 (.1 mg/kg/min.), 7/11/1978

19 17
YOH-10 (.25 mg/kg/min.), 8/19/1978

19 18
YOH-11 (.1 mg/kg/min.), 8/30/1978

19 19
YOH-12 (.25 mg/kg/min.), 9/8/1978

19 20
YOH-13 (.25 mg/kg/min.), 9/8/1978

19 21
YOH-14 (.25 mg/kg/min.), 9/8/1978

19 22
YOH-15 (.025 mg/kg/min.), 9/18/1978

19 23
YOH-16 (.025 mg/kg/min.), 9/18/1978

19 24
YOH-17 (.1 mg/kg/min.), 12/14/1978

19 25
YOH-18 (.1 mg/kg/min.), 12/14/1978

19 26
YOH-19 (.05 mg/kg/min.), 12/15/1978

19 27
YOH-20 (.05 mg/kg/min.), 12/15/1978

19 28
YOH-21 (.05 mg/kg/min.), 12/18/1978

19 29
YOH-22 (.05 mg/kg/min.), 12/18/1978

19 30
YOH-23 (.05 mg/kg/min.), 12/19/1978

19 31
YOH-24 (.0025 mg/kg/min.), 12/20/1978

19 32
YOH-25 (.025 mg/kg/min.), 12/20/1978

19 33
YOH-26 (.025 mg/kg/min.), 12/20/1978

19 34
YOH-27 (.0025 mg/kg/min.), 12/21/1978

19 35
YOH-28 (.0025 mg/kg/min.), 12/21/1978

19 36
YOH-29 (.0025 mg/kg/min.), 12/21/1978

Other experiments, 1952-2003 [subseries]:

152 24
Laboratorie de Biochemie Generale at et Comparee de France, Paris -- experiment binder, 1968-1969

19 37
1. aging -- CBF -- Normal, 1955-1957

19 38
2. aging -- CBF -- hypertension, 1956

19 39
3. aging -- CBF -- arteriosclerosis, 1956-1957

19 40
4. aging -- CBF -- chronic brain syndrome, 1957-1958

19 41
B. aging -- patient material, 1957-1959

19 42
C. Aging -- Statistics, 1958-1959

19 43
C. Aging -- Statistics, 1959

19 44
D Aging -- Inter Correlations, 1959-1960

19 45
E Aging -- research data, 1959-1960

20 1
ANES series, 1993

20 2
ANES 1-5, Jan. 5-11, 1993

20 3
ANES 6-10, Jan. 12-25,1993

20 4
ANES 11-15, Feb. 1-9, 1993

20 5
ANES 16-20, Feb. 16-23, 1993

20 6
ANES 21-25, March 21-31, 1993

20 7
ANES 26-30, March 9-22, 1993

20 8
ANES 31-34, March 23-28, 1993

20 9
ANES, 1992

20 10-11
Arterial curves -- O2 -- C02 series, 1956

20 12-13
Arterial curves -- SCL series [photographs], 1956

20 14
CE-1: lumped constant rat, 5%, CO2 inhal, 1974

20 15
CE-2: lumped constant rat, 5% CO2 inhal., undated

20 16
CE-3: lumped constant rat, 5% CO2 inhal., 1975

20 17
CE-4: lumped constant rat, 5% CO2 inhal., 1975

20 18
CK1, 60 min. normal control, 6/15/1978

20 19
CK2, 60 min., 6/15/1978

20 20
CS-23, 7/10/1978

20 21
CS-24, 8/21/1978

20 22
CS-26, 12/13/1978

20 23
CS-27, 12/14/1978

20 24
G5 Ur W5 V4 original rate constants, undated

20 25
Parameters (V4 V4 G6 W5) pulse experiments -- new 3 rate constants, 1985

20 26
HYP1 (10%), 1/15/1976

20 27
HYP2 (10%), 1/15/1976

20 28
HYP-3 (7.5% O2), 1/21/1976

20 29
HYP-4 (7.5% O2), 1/21/1976

20 30
Hypoxia 10% O2 behavior: observation, 1976

20 31
LCBF summary, undated

20 32
LCBF summary for misc. data, undated

20 33
Sheet for LCBF, undated

20 34
1 washout constant exp., flow rate: 0.8 ml/min., 1991

20 35
2 washout constant exp., flow rate: 1.0 ml/min., 1991

20 36
03 washout constant exp., flow rate: 1.2 ml/min., 1991

20 37
04 washout constant exp., flow rate: 0.6 ml/min., 1991

20 38
05 washout constant exp., flow rate: 1.4 ml/min., 1991

20 39
06 washout constant exp., flow rate: 1.6 ml/min., 1991

20 40
Washout correction for LCBF equation, undated

20 41-42
Wynn project -- alleged non-mitochondrial thyroxine stimulation of protein synthesis -- Nov. 9, 1970

20 43
2 Deoxyglucose Studies (Rat, Cat), 1973-1983

20 44
2.5 min., undated

20 45
5.0 min., undated

20 46
10 min., undated

20 47
15 min., undated

20 48
30 min., undated

20 49
45 min., undated

20 50
60 min., undated

20 51
90 min., undated

20 52
120 min., undated

20 53
14C Toluen internal std. -- lot 0060283A, 1986

20 54
14c-warfarin, 1993

20 55
Abrams -- lumped constant data, 1985

136 11
Absorption Spectra, undated

20 56
Additional structure morphine, undated

20 57
Alfred Benzon symposium, 1990

20 58
Amanda, 12/5/1979

20 59
Amersham standard calibration, 1978

20 60
Analytical ultracentrifuge records [photographs], 1966

20 61
Anesthesia record, undated

21 1
Animal phosphate [photographs], 1978

21 2
AP vs. IAP rat summary, undated

21 3
Arithmetic mean value of gray structures (pulse experiments), 1979

21 4
Arterial blood studies (Tbl 1) (from Reivitch, et. al.) [slides], 1977

21 5
Astroglial exp. -- amino acid analysis key, 1995

21 6
Astroglial exp. -- Dr. Kaufman's cell extract samples, 1995

21 7
Astroglial exp. -- intracellular A.A., 1995

21 8
Atlas -- 1, 1980

21 9
Amino-acid-analyzen, 1992

21 10
A. V. blood curves -- desaturation curves studies, 1952-1956

21 11
Banzo (sleep control), 1980

21 12
Basil, 6/13/1979

21 13
Beckman polygraph calibration, undated

21 14
Blank sheets for experiments, undated

21 15
Crop, 6/25/1979

21 16
Brain development, undated

21 17
Bonzo, film 21, 1985

21 18
Brain -- (Gelber) photos and negatives [photographs, negatives], 1967

21 19
Calibration of plastic standards, 1969-1975

21 20
Calibration of standards, undated

21 21
Calibration standards using the 10 and "new low" standards"", 1986

21 22
Catheter -- calibration exp., 1991-1992

21 23
Catheter smear collection, undated

21 24
Caveness study materials [photographs], undated

21 25
CCK -- vagotomized, 1980

21 26
Chico, 1980-1984

21 27
Chr. Li-1, 5/27/1980

136 12
Chromatogram Records, 1960

21 28
Chronic -- nitro i.p., 1993

21 29-30
Chronic i.p. of L-NAME series vol. 1-2, 1993

21 31
Clinical trials of barbiturates in rats, 1972

21 32
Collaboration -- Bill Eckelman and Juntendo Univ., 1999

21 33
Collaboration -- Dr. David M. Cohen, 2000-2003

21 34
Collaboration -- Dr. Rolf Gruetter -- Univ. of Minnesota, 1999-2001

21 35
Collaboration -- SuperGen, 1999-2000

21 36
Dee, film 8-35, 1978

21 37
Dee, film no. 7-35, 1979

21 38-39
Densitometric calibration curves, 1953-1955

21 40
Densitometry 1, 1953-1954

21 41
Densitometry 2, 1954

22 1
Deoxyglucose review, 1980-1981

22 2
Directories -- disk and tape, 1985

22 3
Discarded animals, 1972

22 4
Dreamless, film 17, undated

22 5
Dreamless, 1980

22 6
ECF mixed culture (counting data), 1995

22 7
ECG, EOG and EMG (from Reivitch, et. Al.) [Slides], 1985

22 8
Effects of barbiturates on blood gases, undated

22 9
Effects of epinephrine on blood glucose, 1958-1959

136 13
Effects of Thiopental Anesthesia on Local Cerebral Glucose Utilization in the Albino Rat, undated

22 10
Equilibrium, undated

22 11
ER-M, C-31'-236 uc., 1973-1974

22 12
Exp. CC1, 1980

22 13
Exp. CC2, 1980

22 14
Exp. CC5, 1980

22 15
Exp. CR2, 1980

22 16
Exp. CR3, 1980

22 17
Exp. CR4, 1980

22 18
Exp. CR6, 1980

22 19
Exp. CR7, 1980

22 20
Experiment 6: raw data -- nucleotide separation by high voltage electrophoresis, 1970

22 21-22
Factor preparation and properties -- book 2, 1968-1974

22 23
Factor TLC scans, 1969

22 24
Failed experiment, Aug. 22, 1991

136 14
Fasting and Brain Metabolism, 1969-1973

136 15
G. Fitzgerald Experiments, 1971

22 25
G5 U4 with new 3 rate constants -- Ki*=.232, K2*=.240, K3*=0.61, 1985

22 26
GEE -- experiment work sheep, 1978-1979

22 27
GEE file no. 7-33, 1979-1980

22 28
Glucose deter.: Beckman vs. Gilford, 1975

22 29
Glucose deter.: with glass vs. Eppendorf pipets, 1975

22 30
Glucose determination (spectrophotometer), undated

22 31
Glucose determination: glucose oxidase method, undated

22 32
Glucose determination: miscellaneous, 1973-1975

22 33
GU-BMF (multi-film program), undated

22 34
Guide to reading auto radiographs, undated

22 35
Hemoglobinometry, 1979

22 36
HG misc., 1980

22 37
High-std-1, 14c meth. Glucose, 1978

22 38
History: rat thyroidectomies, 1960-1966

22 39
Hydroxybuty rate assay, 1969

22 40
Hyperinsulinemia experiments, 1980

22 41
Info. on micropipettes and pumps, 1973

22 42
Insulin hypoglycemia (50 uci/animal), undated

22 43
Internal standard, 1985

22 44
L.S. brain -- I, 1977

22 45
Laplace transform -- technical info., 1975

22 46
Liquid scintillation media, 1974

22 47
List of research projects planned, undated

22 48
Low standard I graph, 1977

22 49
LSD-DG series, 1975-1976

22 50
M. Shionohara -- summarized date, 1979

22 51
Manuscript -- Dr. Sokoloff [photographs], undated

22 52
Marburg slides, undated

22 53
Mean weighted average (GU) -- square exp. (GU was calculated with weighted average of tissue conce.), 1979

22 54
Mean weighted average of GU (GU was directly calculated by image processor), undated

22 55
Metabolic maturation of the brain in relation to asphyxia neonatorum, 1963-1964

22 56
Milt, 6/14/1979

22 57
Milt, film no. 1-32, 1979-1982

22 58
Misc. papers, 1979-1980

22 59
Miscellaneous statistical analyses, 1960

22 60
Mixed and astroglial culture, 1995

22 61
Morphine summary, undated

22 62
MTZ-1, 1/1/1975

22 63
MTZ-2, 1/2/1975

22 64
N.E.N. standard calibration, 1978-1979

23 1
NH3 -- 1-3, HF -- 1-2, GD -- 1-3, DLX, DX 1-4 Rats [X- Rays], 1977

23 2
N.O.S. assay, 1992-1993

23 3
Nitro i.p. -- enzyme assay, 1993

23 4
No synthase assay, 1992-1993

23 5
NOD, 3/18/1980

23 6
Nodoz [photographs], 4/8/1980

23 7
Nodoz, film 6, 1980

23 8
NOS activity after nitroarginine intracisternal infusion, 1993

23 9
Nose, 3/22/1979

23 10
OD vs. con. x time, undated

23 11
Olf. Bulb, undated

23 12
Original 3-rate constants, 1986

23 13
Parameters (pulse experiments ) 5 rate constants (K4*=0.0014), 1986

23 14
Parameters (pulse experiments) -- 5 rate constants (K4*=0.002), 1986

23 15
Parameters (square exp.) 5 rate constants, 1986

23 16
Parsley, 7/10/1980

136 16
Peroxidase Kinetics -- Model #1, undated

136 17
Peroxidase Kinetics -- Model #2, undated

136 18
Peroxidase Kinetics -- Model #3, undated

23 17
Phosphate, 1979

23 18
Phosphate, 1978

23 19
Physiological conditions' summary -- pulse exp., undated

23 20
Plasma curves, undated

23 21
Poly. fitting -- plastic standards, 1973

23 22
Posh, 8/6/1980

23 23
Pulse experiments parameters -- 5 rate constants (K4*=0.001), 1986

23 24
Pump schedule sheet, undated

23 25
Puromycin -- originals negatives [negatives], undated

23 26
Psychological vs. Physiological, 1961

23 27
Radiochemical specifications, 1967-1974

23 28
Rat DX-4, 1971

23 29
Rate constant experiments, 1970-1992

23 30
Red-outline drawings, undated

23 31
REM4, awake cont. cat, 1976

23 32
REM5, 1976

23 33
Reproduce Iadecola's experiment, 1992

48 28
Research medicine [experiment proposal], 1992

23 34
Reza, 9/10/1979

23 35
Ribosomal protein -- orig. photos and neg. [photographs, negatives], undated

23 36
Roche system -- originals and photographs [negatives], undated

23 37
Rocky, undated

23 38
Rocky, 10/26/1978

23 39
Rocky, film no. 1-32, 1979

23 40
Sakurada abstract -- effects of immobilization, 1977

23 41
Salicylates -- illus. and negatives [negatives], undated

136 19
Separation of AMP, ADP, and ATP Using Electrophorisis, 1970-1971

23 42
Series AB: laplace transform, 2 DG. rats: BARB. ANES, 1975

23 43
Series AUD-111: auditory alterations, 1973

23 44
Series AUD-2: auditory alterations, 1974

23 45
Series AUD-3: auditory alterations, 1974

23 46
Series AUD-4: auditory alterations, 1974

23 47
Series CB: laplace transform, 2DG. rats: 5% CO2, 1975

23 48
Series NH: ammonium acetate -- 10 m. moles/kg i.p., 1972

23 49
Series normal: normal values in rats, 1971

23 50
Series R-ER-1 to R-ER-7 -- trial at square wave rats -- conscious, 1974

23 51
Series WB: laplace transform, 2DG rats: conscious, 1975

23 52
Shaky [photograph], 12/20/1979

23 53
Short counts on Beckman L.S5801, 1985

23 54
Sierra, 1980-1984

23 55
Sleep -- spinal cord, undated

24 1
Sleep (end Kennedy files), 1980

24 2
Sleep 1 (fang), 2/13/1980

24 3
Sleep study, 1981-1990

24 4
Snooz, 1/5/1980

24 5
Sparky -- myelinated [photographs], 1983

24 6
Spot -- sleeping, 2/12/1981

24 7
Standard calibration, 1979

24 8
Standard strip calibration from G. Dauth, neurosci., Univ. of Mich., Feb. 9, 1980

24 9
Standards, 1979-1983

24 10
Sugar, 1979

24 11
Sugar, film no. 1-28, 1979

24 12
Summarized data for computer analysis, undated

24 13
Summary of parameters (pulse exp.) (square exp.), undated

24 14
Summary of parameters (square exp), undated

24 15
Summary sheets, 1968-1974

24 16-20
Summary tables and graphs, undated

24 21
T3 Be Vwa time course data for Dr. Greenhouse, undated

24 22
Tent rat training record, 1993

24 23
TSC-1, Nov. 10, 1975

24 24
TSC-2, Dec. 1, 1975

24 25
TSC-3, Dec. 2, 1975

24 26
TSC-4, Dec. 4, 1975

136 20
University of Pennsylvania [Research Notes], 1950-1953

136 21
[Unidentified Research Notes], [circa 1950s]

24 27
Values of rate constants in the normal conscious albino rat, undated

24 28
Visual alteration: enucleation, 1973

24 29
Weighted average concentration -- (pulse experiments) Dr. Shinohara's data, 1986

24 30
Whole blood samples, undated

24 31
Windy, 1978

24 32
Windy [photograph], 1978-1979

24 33
Windy, film no. 7-33, 1978

24 34
Winx, 1985

24 35
Winx (sleep control), 1980

24 36
Winx, film 16, 1987

Research Notebooks, 1952-2002 [subseries]:

24 37
A -- 9 5 HTT Mice, 2002

24 38
Aldose reductase, 1989

25 1
Alison's notebook -- Cathy, 1989

25 2
Alison's notebook -- C-fox S-S rats, 1989-1990

25 3
Alison's notebook -- hematology plates (property of J. D. Brown HMI), 1956

25 4
Alison's notebook -- HRP ganglion and stimulation [photograph], 1982

25 5
Alison's notebook -- hypothyroid rats, 1979-1980

25 6
Alison's notebook -- ICSS surgery, 1981-1989

25 7-8
Alison's notebook -- ICSS testing book, 1984-1987

25 9
Alison's notebook -- Lida's baby rats, 1982

25 10
Alison's notebook -- LSU series, autoradiography and histology, 1986

25 11
Alison's notebook -- MFB rats, 1989

25 12
Alison's notebook -- new protocol for temp. experiments, undated

25 13
Alison's notebook -- papers/protocols, 1989-1990

25 14
Alison's notebook -- rats, 1988

25 15
Alison's notebook -- temp. experiments, 1987

25 16
Alison's notebook -- water rats, undated

25 17
Animal record book, 1958-1960

25 18
Annual report -- laboratory of clinical science, 1962-1963

25 19
Assays, enzymes and preparations, 1958-1966

25 20
Autoradiography, 1976-1977

25 21
Autoradiography, 1979

26 1
Autoradiography, 1994-1996

26 2
Autoradiography book I and book II, 1978

26 3
Bay K 8644, 2000

26 4
Blood oxygen book I, 1954-1957

26 5
Bilateral CBF St. Elizabeth's, 1962-1964

26 6
Brain G-6pase rate constants K4K5, 1990-1993

26 7
CY Bay K continuous Infusion (wisker 2D G), 2001

26 8
Dr. Kennedy and Alison -- perfused 2 DG animals, 1979

26 9
Durell, 1954

26 10
Elaine Kaufman notebook: book 1 -- enzyme purification, 1986-1987

26 11
Elaine Kaufman notebook: book 2 -- enzyme purification, 1987-1988

26 12
E. Kaufman notebook: GLIA -- I, 1986-1988

26 13
E. Kaufman notebook: GHB dehydrogenase II, 1982

26 14
GLIA 4, 1993-1994

26 15
E. Kaufman notebook: GLIA -- book 5, 1995

26 16
E. Kaufman notebook: GLIA -- neurons, book 6, 1996-1997

27 1
Elaine Kaufman notebook: GLIA -- neurons (book -- 7), 1998-1999

27 2
E. Kaufman Notebook: Book IX, 1971-1972

27 3
E. Kaufman notebook: survey book, 1972-1981

27 4
Elaine Kaufman notebook -- GHB enzyme in GLIA and neurons, 1988

27 5
Elaine Kaufman notebook: GHB, 1984-1985

27 6
Elaine Kaufman notebook: GHB clinical studies, 1984-1985

27 7
Elaine Kaufman notebook: GHB-C-AMP, book I, 1991-1992

27 8
Elaine Kaufman notebook: GHB degradation II, 1985-1986

27 9
Elaine Kaufman notebook: GHB degradation III, 1986-1989

27 10
Example of experimental protocols -- factor method -- Patricia A. Roberts, 1966-1968

27 11
GHB-C-AMP, book II, 1992-1994

27 12
GB- 19 -GB22 -- HLI -- HL25 -- GB25 -- GB30, 1999

27 13
GB31 -- 52 -- GM1 -- 20, 2000

27 14
GHB biosynth. -- B40, 1986-1993

27 15
GHB-Dehydrogenase preparation, 1979-1980

28 1
Glucose, 1957-1959

28 2
Glucose determination, 1955-1957

28 3
Haloperidol (HX) -- Glibenclamide (GB), 1999

28 4
IAP book I, undated

28 5
Instruments, 1952-1957

28 6
J.D., 1952-1955

28 7-17
Jane Pietrosewicz -- autoradiography books, 1980-1992

29 1-3
Jane Pietrosewicz -- autoradiography books, 1993, 1996-2002

29 4
K- Channel Opener, undated

29 5
L. Libow data, 1961

29 6
Large scale assay, 1967-1969

29 7
Micro analysis of Iodine in Tissues, 1955

29 8
Miscellaneous experiments, 1959-1968

29 9
Miscellaneous preparation, assays, 1969

29 10
Miscellaneous Warburg experiments, 1956-1958

29 11
ND 28-31 CK 15-, 2002

29 12
Nifedipine, 2001

29 13
Nimodipine (ND) -- Ibenotoxin (CK), 2001

29 14
Nitrogen determination -- book I, 1958-1962

29 15
Nitrogen determination -- book 2, 1962-1967

29 16
Nitrogen determination -- book III, 1967

29 17
Note book -- Jane Jehle, 1964-1975

29 18
Organic synthesis -- book I, 1959

29 19
Oxidative phosphorylation -- book 2, 1958

29 20
Personal solutions 1, 1970-1972

30 1
PH., 1956-1958

30 2
Phosphate determinations -- book 1, 1962-1969

30 3
Phosphate determinations -- book II, 1969

30 4
Preparations of ribosomes -- book 1, 1963-1966

30 5
Preparations of SRNA amino acid -- book IA, B, and C, 1961

30 6
Preparations of SRNA amino acids -- book II-C, 1961-1964

30 7
Preparations of SRNA amino acids -- book III-C, 1965

30 8
Protein determinations -- Biuret method, 1971

30 9
Protein determinations -- Kjeldahl method, 1963-1964

30 10
Protein determinations: Lowry method -- book 1, 1963-1967

30 11
Protein determinations: Lowry method -- book 2, 1967-1971

30 12
Protein determinations: Lowry method -- book 3, 1972

30 13
Pyruvate carobxylase in brain -- GLIA II, 1988-1989

30 14
R. Neill, 1973

30 15-20
Research notebook -- book 1-6, 1970-1972

31 1-14
Research notebook -- book 4-17, 1958-1963

32 1
Research notebook -- book 18, 1963

32 2
Research notebook -- book 19F, 1964-1965

32 3
Research notebook -- book 19M, 1964-1966

32 4-9
Research notebook -- book 20F-25F, 1965-1969

32 10
Research notebook -- book 1BR, 1960-1970

32 11-14
Research notebook -- book 2T-5T, 1964-1966

33 1-7
Research notebook -- book 6T-12T, 1966-1967

33 8-12
Research notebook -- book 7-11, 1972-1973

33 13
Research notebook -- book IIA, 1961

33 14
Research notebook -- book IIB, 1961-1962

33 15
Research notebook -- book IIIA, 1962-1963

33 16
Research notebook -- radioactive phosphate and adensive nucleotide experiment, 1960-1965

33 17
Research notebook -- salicylate effects on amino acid incorporation (SEOAAI) -- book 1, 1966

33 18-22
Research notebook (SEOAAI) -- book 2-6, 1966-1967

33 23
RLK solutions I, 1964-1966

34 1-2
RNA determinations -- book 1 and 2, 1963-1967

34 3
Salicylate, 1966

34 4
Section on cerebral metabolism, 1954-1958

34 5
Section on cerebral metabolism -- sample wts. for radioactive assay PH, 1956-1958

34 6
Section on cerebral metabolism -- 26F, 1970

34 7
Section on cerebral metabolism -- 27F, 1970-1974

34 8
Section on cerebral metabolism -- book 1, 1958-1959

34 9
Section on cerebral metabolism -- EP + Nor EP -- book 1, undated

34 10
Sleep, 1966

153 7
[Sleep] Dr. Kety, 1950-1951 [RESTRICTED PHI]

153 8
[Sleep] Mental activity #2, 1952 [RESTRICTED PHI]

34 11-12
Solutions -- B. A. Jant Franke, 1966-1973

34 13
Solutions -- B38, 1985-1994

34 14-16
Solutions -- book I, 1956-1965

34 17
Solutions IV, 1965-1966

34 18
Solutions VI, 1973-1976

34 19
Solutions -- local protein synthesis, 1982

34 20
Solutions, T. Nelson, 1975-1984

35 1
Specifications and criteria for biochemical compounds, 1960

35 2
Spectophotometry, 1954-1958

35 3
Spectrophotometry 2 -- 02 saturation blood, 1957-1958

35 4-5
Sydell Gelber, 1959-1960

35 6
Synthesis of monoiodohistidine, 1968

35 7
The effect of thyroid hormone on purified kinase enzymes -- book I, 1967

35 8
Thyroid Mice Study, 2001

35 9
Thyroid solutions, 1966-1967

153 9
Thyroid, 1948-1949 [RESTRICTED PHI]

153 10
Thyroid (concluded), 1951-1952 [RESTRICTED PHI]

35 10
Van Slyke analyses, 1955-1956

35 11
Van Slyke manometer -- book I, 1954-1956

35 12
Van Slyke manometer -- book III, 1955-1956

35 13
Van Slyke -- Gladys Ellis -- book IV, 1956-1958

35 14
Van Slyke data -- book V, 1956-1958

35 15
Van Slyke -- book VI, 1958

35 16
Warburg calibration -- standard solutions, 1957-1959

35 17
Warburg experiments -- book 1, 1955-1957

Research Data PET Scans, 1953-2002, undated [subseries]:

Numbered, 1981, undated [subseries]:

50 1
1 autoradiograph with standard [photographs, negative], undated

50 2
2 DG + DG2 + MG molecules [photographs, negative], undated

50 3
3 DG through brain barrier [photographs, negative], undated

50 4
4 functional anatomy of operational -- *DG equ. [photographs, negative], undated

50 5
5 lumped constant in several species [photographs, negative], undated

50 6
6 glucose utilization in conscious rat and monkey [photographs, negative], undated

50 7
7 effects of thiopental anesthesia on cerebral glucose utilization [photographs, negative], undated

50 8
8 spinal cord effects of unilateral stimulation [photographs, negative], undated

50 9
9 relationship between frequency of stimulation and LGU [photographs, negatives, slides], undated

50 10
10 focal seizure during LGU [photographs, negatives], undated

50 11
11 otitis [photographs, negatives], undated

50 12
12 left eye removed (rat) L.G.U. [photographs, negatives], undated

50 13
13 coronal brain (monkey) [photographs, negatives], undated

50 14
14 coronal brain (monkey) -- rt. eye occluded, undated

50 15
15 [negative], undated

50 16
16 12 hr. lt./12 hr. dk. (glucose utilization) [photographs, negative], undated

50 17
17 apomorphine rt. eye enucleated [photographs, negative], undated

50 18
18 effects of d- and 1- amphetamine on LCGU in rat [photographs, negative], undated

50 19
19 computer diagram image display system [photographs, negative], undated

50 20
20 average brain cerebral glucose utilization [negative], undated

50 21
21 ageing and metabolism [photographs, negative], undated

50 22
22 ageing and metabolism [photographs, negative], undated

50 23
23 ageing and metabolism, LCGU vs. apomorphine [photographs, negative], undated

50 24
24 ageing, LCGU vs. apomorphine [photographs, negative], undated

50 25
25 LCGU vs. aopmorphine (subthalamic nucleus and inferior olivary nucleus) [photographs, negative], undated

50 26
26 LCGU vs. apomorphine (ageing) [photographs, negative], undated

50 27
27 DG, FDG, CH3 -- glucose, brain pictures [photographs, negative], undated

50 28
28 glucose metabolic rate (FDG) [photographs, negative], undated

50 29
29 LCGU vs. apomorphine (age), undated

50 30
30 LCBF w/[I125] Hipdm vs. [C14} idoantipyrine [photographs, negative], undated

50 31
31 LCBF indicator fraction method [photographs, negative], undated

50 32
32 spreading depression [photographs, negative], undated

50 33
33 [photographs, negative], undated

50 34
34 electrical stimulation and DG* uptake in pituitary [negative], undated

50 35
35 socium pump and neurosecretion effects on DG* uptake [photographs, negative], undated

50 36
36 [125] hipdm and products vs. radioactivity in arterial blood [photographs, negative], undated

50 37
37 radioactivity DPM vs. time curves [photographs, negative], undated

50 38
38 spreading cortical depression (KCI) [photographs, negative], 1981

50 39
39 osmotic opening of BBB [photographs, negative], undated

50 40
40 blood flow vs. LGU in conscious and anesthetized [photographs, negative], undated

50 41
41 [photographs, negative], undated

50 42
42 glucose utilization in dark-adapted rats (saline vs. apomorphine) [photographs, negative], undated

50 43
43 dark-adapted rats (eye enucleated) saline vs. apomorphine [photographs, negative], undated

50 44
44 effects of light intensity on LGU [photographs, negative], undated

50 45
45 [125I] hipdm single pass extraction vs. venous [photographs, negative], undated

50 46
46 deosyglucose vs. glucose in arterial and venous [photographs, negative], undated

50 47-48
47 influence of rate constants on integrated pool specific activity [photographs, negative], undated

50 49
48 rate constants in the normal conscious albino rat [negative], undated

50 50
49 lump constant vs. time [photographs, negative], undated

50 51
50 cerebral metabolism of [14C] DG and G in vivo [photographs, negative], undated

50 52
51 blood CO2 curves [photographs, negative], undated

50 53
52 striate cortex (monkey) [photographs, negative], undated

50 54
53 autoradiograph dorsolateral surface of monkey occipital lobe [photographs, negative], undated

50 55
54 LCGU vs. apomorphine [photograph, negative, slides], undated

50 56
55 systems involved in higher functions [negative], undated

50 57
56 auditory system (LCGU) [negative], undated

50 58
57 auxtomy, leucine protein synthesis [photographs, negative], undated

50 59
58 auxtomy, DG, protein synthesis nissl stain [photographs, negative], undated

50 60
59 3H and 24C DG [photographs, negative], undated

50 61
60 brain anatomy labeled [photographs, negative], undated

50 62
61 experimental period effects on gray matter glucose utilization [photographs, negative], undated

50 63
62 visual stimulus (3H] DG [photographs, negative], undated

50 64
63 pretectal nucleus [photographs, negative], undated

50 65
64 visual cortex [photographs, negative], undated

50 66
65 lateral geniculate nucleus [photographs, negative], undated

50 67
66 posterolateral nucleus of the thalamus [photographs, negative], undated

50 68
67 blood flow vs. LCGU (control) [photographs, negative], undated

50 69
68 blood flow vs. LCGU (acidosis) [photographs, negative], undated

50 70
69 blood flow vs. LCGU (acidosis and control) [photographs, negative], undated

50 71
70 antidromic stimulation of superior cervical ganglion [photographs, negative], undated

50 72
71 superior colliculus LCGU vs. light intensity [photographs, negative], undated

50 73
72 *DG and *DG-6-phosphate concentration over time [photographs, negative], undated

50 74
73 antidomic stimulation of superior cervical ganglion [photographs, negative], undated

50 75
74 antidromic stimulation of superior cervical ganglion [photographs, negative], undated

50 76
75 air embolism and control in K+ concentration [photographs, negative], undated

50 77
76 air embolism and control in pH of injection fluid [photographs, negative], undated

50 78
78 post axotomy and control [photographs, negative], undated

50 79
80 [photographs, negative], undated

50 80
81 hypoxemia [photographs, negative], undated

50 81
82 darkness vs. 700 lux (pigmented rats) [photographs, negative], undated

50 82
83 hypoxemia [photographs, negative], undated

50 83
84 hypoxemia [photographs, negative], undated

50 84
85 darkness vs. 700 lux (albino rats) [photographs, negative], undated

50 85
86 newborn monkey [photographs, negative], undated

50 86
87 [photographs, negative], undated

50 87
88 spinal cord [photographs, negative], undated

50 88
89 globus pallidus, etc. [negative], undated

50 89
90 reginal glucose utilization [photographs, negative], undated

50 90
91 reginal glucose metabolism after 10 min. cerebral ischemia in the rat [photographs, negative], undated

50 91
92 [photograph], undated

50 92
93 left eye removed [photographs, negative], undated

50 93
94 penn. seizure antipyrine, baby monkey [photographs, negative], undated

50 94
95 effects of thiopental anesthesia on cerebral glucose utilization [photograph], undated

50 95
97 equilibration of glucose specific activity between plasma and brain [photographs, negative], undated

50 96
98 influence of duration on glucose utilization [photographs, negative], undated

50 97
99 relationship between stimulation and L.G.U. [photographs, negative], undated

50 98
100 determination of glucose specific activity [photographs, negative], undated

50 99
101 brain-plasma glucose equilibration, undated

50 100
102 tissue glucose pool 1/2 life vs. plasma glucose concentration [photographs, negative], undated

50 101
103 glucose activity in plasma, tissue [negative], undated

50 102
104 cerebral 02 consumption in cerebral blood flow [photographs, negative], undated

50 103
105 half-lives of DG*-6-P in grey and white matter [photographs, negative], undated

50 104
106 arterial and venous [ ] of 14c D.G. following i.v. in a cat [photographs, negative], undated

50 105
107 derivation of operational method for measurement of LCGU [photographs, negative], undated

50 106
108 tissue pool 1/2 life [photographs, negative], undated

50 107
109 math. analysis of model for total accumulation of DG* and DG*-P [photograph, negative], undated

50 108
110 theoretical calculation of [14c] DG-6-P in rat brain [photographs], undated

50 109
111 general equation + influence of phosphotase activity [photograph, negative], undated

50 110
112 lumped constant calculation used by Hawkins and Miller [photographs], undated

50 111
113 [photograph], undated

50 112
114 equation for changing plasma glucose concentration [photograph, negative], undated

50 113
115 BBB model and equation of 14C glucose uptake [photograph, negative], undated

50 114
116 glucose uptake model + equation [photographs, negative], undated

50 115
117 LCGU in conscious albino and pigmented rats [negative], undated

50 116
118 glucose utilization in sensorimotor systems [negative], undated

50 117
119 glucose utilization in myelinated fiber tracts [negative], undated

50 118
120 glucose utilization in limbic system [negative], undated

50 119
121 glucose utilization in conscious and restrained rats [negative], undated

50 120
122 glucose utilization of the visual system [negative], undated

50 121
123 1/2 life of tissue pool in male rats [negative], undated

50 122
124 turnover of tissue glucose pool in male rats [negative], undated

50 123
125 values of rate constants in normal conscious albino rats [photographs, negative], undated

50 124
127 conditions w/altered function in CNS w/out change in average body metabolism [photograph], undated

50 125
128 relationship between consciousness and cerebral metabolic rate [photograph], undated

50 126
129 sodium pump and neurosecretion effects on DG* uptake, undated

50 127
130 functional anatomy of the DG*method equ. [photographs, negative, slide], undated

50 128
131 operational equation of [14C] DG method [photographs, negatives], undated

50 129
132 plasm -- tissue B-B-B (revised by Smith) [photographs, negatives], undated

50 130
135 LCBF with hipdm indicator fractionation method [photographs, negatives], undated

50 131
136 [14c] glucose-6-P single pass extraction fraction [photographs, negatives], undated

50 132
137 LCBF w/[I125] hipdm tissue equilibration method [photographs, negatives], undated

50 133
138 retinal stimulation in rats [photographs, negatives], undated

50 134
139 local cerebral glucose utilization [photographs, negatives], undated

50 135
140 local cerebral blood flow [photographs, negatives], undated

50 136
141 kinetics of competitive substrate reactions [photographs, negatives], undated

50 137
142 CBF and CMR 02 vs. years [photographs, negatives], undated

50 138
143 influence of CO2 in correlation between LCBF and LCGU [photographs, negatives], undated

50 139
144 monkey [photographs, negatives], undated

50 140
145 glucose utilization vs. stimulation frequency [photographs, negatives], undated

50 141
146 operational equation of [14C] deoxyglucose method [photograph], undated

50 142
147 cervical ganglion drawing [photographs, negatives], undated

51 1
148 cervical ganglion drawing [photographs, negatives], undated

51 2
149 cervical ganglion (micro) [photographs, negatives], undated

51 3
150 effects of apomorphine upon glucose utilization in habenula [photographs, negatives], undated

51 4
151 LCGU vs. halperidol [photographs, negatives], undated

51 5
152 LCGU vs. apomorphine [photographs, negatives], undated

51 6
153 preanglionic holinergic fibers [photographs, negatives], undated

51 7
154 pre-ganglionic cholinergic [photographs, negatives], undated

51 8
155 focal seizures -- protein synthesis [photographs, negatives], undated

51 9
156 focal seizures (metabolic effects) [photographs, negatives], undated

51 10
157 optical density, apomorphine vs. halperidol [photographs, negatives], undated

51 11
158 apomorphine vs. haloperidol (magnification) [photographs, negatives], undated

51 12
159 slide to side differences in monkey brain structures [photographs, negatives], undated

51 13
160 LGU in monkey brain [photographs, negatives], undated

51 14
161 influence of age on responsiveness to apomorphine [photographs, negatives], undated

51 15
162 influence of age on responsiveness to apomorphine (zona compacta) [photographs, negatives], undated

51 16
163 influence of age on responsiveness to apomorphine (aged 48-67) [photographs, negatives], undated

51 17
164 cervical ganglion [photographs, negatives], undated

51 18
165 regional glucose utilization [photographs, negatives], undated

51 19
166 regional glucose utilization (ketamine) [photographs, negatives], undated

51 20
167 regional glucose utilization (limbic system) [photographs, negatives], undated

51 21
168 regional glucose utilization: auditory, visual, sensory [photographs, negatives], undated

51 22
169 physiologic pearmeters [photographs, negatives], undated

51 23
170 LCGU (percentage change from control) [photographs, negatives], undated

51 24
171 LCGU (percentage change from control) ketamine [photographs, negatives], undated

51 25
172 blood flow transport and metabolism [photographs, negatives], undated

51 26
173 SSA vs. 1/[GHB] [photographs, negatives], undated

51 27
174 SSA or NADPH vs. 1/[NADP+] [photographs, negatives], undated

51 28
175 SSA or NADPH vs. time [photographs, negatives], undated

51 29
176 1/[GHB] vs NADPH, NADPH vs. 1/[NADPH] [photographs, negatives], undated

51 30
177 NADPH vs. 1/[NADPH] and 1/[GHD] [photographs, negatives], undated

51 31
178 SA vs. [GHB] and [D-glucuronate] [photographs, negatives], undated

51 32
179 apomorphine substantia nigra young vs. aged rats [photographs, negatives], undated

51 33
180 monocular deprivation (neonatal monkey) [photographs, negatives], undated

51 34
181 naftidro furyl [photographs, negatives], undated

51 35
182 hypoxemia metabolic raes [photographs, negatives], undated

51 36
183 lateral genic (monkey) [photographs, negatives], undated

51 37
184 ketamine [photographs, negatives], undated

51 38
185 norepinephrine vs. LCGU [photographs, negatives], undated

51 39
186 norepinephrine vs. control LCGU [photographs, negatives], undated

51 40
187 LCGU in white matter during hypoxemia [photographs, negatives], undated

51 41
188 awake/asleep, striate cortex and sensory-motor cortex [photographs, negatives], undated

51 42
189 lumped constant vs. plasma glucose [photographs, negatives], undated

51 43
190 superior cervical ganglia/glucose utilization [photographs, negatives], undated

51 44
191 coeliac and cardiac ganglia/glucose utilization [photographs, negatives], undated

51 45
192 hexokinase synthesis chart [photographs, negatives], undated

51 46
193 physiological variables in hypoxemia [photographs, negatives], undated

51 47
194 average rate of G.U. in whole brain during hypoxemia [photographs, negatives], undated

51 48
195 captopril effects on G. U. of subfornical organ in Brattleboro rats [photographs, negatives], undated

51 49
196 deoxyglucose autoradiographs of cat lumbar spinal cord [photographs, negatives], undated

51 50
197 lumbar spinal cord + brain autoradiographs and stained [photographs, negatives], undated

51 51
198 hyperglycemia lumped constant [photographs, negatives], undated

51 52
199 time course of arterial and venous concentrations of DG* and G [photographs, negatives], undated

51 53
200 model for behavior of leucine in brain [photographs, negatives], undated

51 54
201 glucose clamp [photographs, negatives], undated

51 55
202 lumped constant at different plasma glucose levels, undated

51 56
203 conversion of leucine to acetoacetic acid and acetyl-coenzyme A [photographs, negatives], undated

51 57
204 metabolic rates during hypoxemia [photographs, negatives], undated

51 58
205 axotomy hypoglossal nucleus [photographs, negatives], undated

51 59
206 derivation of operational equ.-model I [photographs, negatives], undated

51 60
207 behavior of leucine in brain model [photographs, negatives], undated

51 61
208 differential equations leucine [photographs, negatives], undated

51 62
209 behavior of leucine in brain model 2 [photographs, negatives], undated

51 63
210 differential equations leucine II [photographs, negatives], undated

51 64
211 derivation of operational equ. -- model III [photographs, negatives], undated

51 65
212 leucine brain -- model III [photographs, negatives], undated

51 66
213 differential equations model III [photographs, negatives], undated

51 67
214 derivation of operational equ. model III [photographs, negatives], undated

51 68
215 derivation of operational equ. III continued [photographs, negatives], undated

51 69
216 derivation of equation [photographs, negatives], undated

51 70
217 model IV -- amino acid incorporation into protein [photographs, negatives], undated

51 71
218 derivation of operational equ. model IV [photographs, negatives], undated

51 72
219 derivation of operational equ. -- model IV continued [photographs, negatives], undated

51 73
220 lumped constant in hypoglycemia [photographs, negatives], undated

51 74
221 DG model -- intracellular and extracellular spaces [photographs, negatives], undated

51 75
222 LCGU kates of insulin-induced hypoglycemia rats [photographs, negatives], undated

51 76
224 physiological variables during insulin-induced hypoglycemia [photographs, negatives], undated

51 77
225 determination of the 1/2 life of the precursor leucine pool [photographs, negatives], undated

51 78
226 synthesis and catabolism of histamine, undated

51 79
227 determination of activity of L-leucine and TRNA-bound leucine [photographs, negatives], undated

51 80
228 scheme for oxidation of [ ]-yydroxybutyrate/ reduction of D-glucuranate [photographs, negative], undated

51 81
229 superior cervical ganglia (G.U. vs. time) [photographs, negative], undated

51 82
230 synaptic mechanisms for histamine neurons [photographs, negative], undated

51 83
231 visual cortex of monkey [photographs], undated

51 84
232 fetal sheep [photographs, negative], undated

51 85
233 fetal sheep? [photographs, negative], undated

51 86
234 saphenous nerve stimulation during anesthesia [photographs, negative], undated

51 87
235 monkey columns [photographs, negative], undated

51 88
236 norepinephrine vs. control LCGU [photographs, negative], undated

51 89
237 autradiographic resolutions [photographs, negative], undated

51 90
239 layer thickness 3H activity [photographs, negative], undated

51 91
240 LandR hemisphere [photographs, negative], undated

51 92
241 functional anatomy of the operational equ. of the 14c DG method [photographs, negative], undated

51 93
242 [photographs, negative], undated

51 94
243 [photographs, negative], undated

51 95
244 [photographs, negative], undated

51 96
245 olfactory bulbs [photographs, negative], undated

51 97
246 relative optical density [photographs, negative], undated

51 98
247 hot hole plug [photographs, negative], undated

51 99
248 brain standards 3H and 14c [photographs, negative], undated

51 100
249 goldfish retinas [photographs, negative], undated

51 101
250 somata cells labeled and unlabeled [photographs, negative], undated

51 102
251 cat muscle, 24c DG [photographs, negative], undated

51 103
252 3H DG water solution frozen in plasma [photographs, negative], undated

51 104
253 grain density in buccal ganglion [photographs, negative], undated

51 105
254 olfactory bulb in tiger salamander 3HDG [photographs, negative], undated

51 106
255 3HDG -- optic lobes of dorsophila melanogaster [photographs, negative], undated

51 107
256 relationship of aggression to onset of lidocaine seizures [photographs, negative], undated

51 108
257 autoradiographic calibration curves vs 3H concentration [photographs, negative], undated

51 109
258 [photographs, negative], undated

51 110
259 occular dominance newborn [photographs, negative], undated

51 111
260 position-emitting atom [photographs, negative], undated

51 112
261 [14C] and [3H] methylglucose [photographs, negative], undated

51 113
262 mid and posterior hypothalamus [photographs, negative], undated

51 114
263 anterior hypothalamus [photographs, negative], undated

51 115
264 dopamine pathways [photographs, negative], undated

51 116
265 integrated tissue specific activity [photographs, negative], undated

51 117
266 energy metabolism in the hypothalamus: effects of reproductive hormones [photographs, negative], undated

51 118
267 integrated tissue sp. ac. [photographs, negative], undated

51 119
268 integrated tissue sp. ac. [photographs, negative], undated

51 120
269 integrated tissue sp. ac. [photographs, negative], undated

51 121
270 GHB-dehydrogenase [photographs, negative], undated

51 122
271 GHB-dehydrogenase [photographs, negative], undated

51 123
272 GHB-dehydrogenase [photographs, negative], undated

51 124
273 GHB-dehydrogenase [photographs, negative], undated

51 125
274 GHB-dehydrogenase [photographs, negative], undated

51 126
275 ESN and WFN, Italy (Smith) [negatives], undated

51 127
276 columns in striate cortex (monkey) [photographs, negatives], undated

51 128
278 computer -- block diagram, undated

51 129
279 hypoxic rat injected with black microspheres, undated

51 130
280 dopaminerglic systems influence [photographs, negative], undated

51 131
281 apomorphine vs. saline on LGU [photographs, negative], undated

51 132
282 ocular dominance columns in monkey [photographs, negative], undated

51 133
283 effects of slow-wave sleep on LGU [photographs, negative], undated

51 134
284 subfornical organ in Battleboro [photographs, negative], undated

51 135
285 neural lobe LGU [photographs, negative], undated

51 136
286 two compartment model for the behavior of leucine brain -- model V [photographs, negative], undated

51 137
287 model VI for behavior of L-leucine in brain [photographs, negative], undated

51 138
288 GHB and GABA levels in rat brain [photographs, negative], undated

51 139
289 cytosol -- rat [photographs, negative], undated

51 140
290 GHB levels -- rat kidney [photographs, negative], undated

51 141
291 GHB dehydrogenase activity in rat kidney [photographs, negative], undated

51 142
292 GHB -- dehydrogenase activity in rat brain [photographs, negative], undated

51 143
293 apomorphine effect on different areas [photographs, negative], undated

51 144
294 superior cervical ganglion -- frequency [photographs, negative], undated

51 145
295 lump constant theoretical derivations [photographs, negative], undated

51 146
296 comparison -- LGU with 3H DG and 14C DG [photographs, negative], undated

51 147
298 bar test after morphine [photographs, negative], undated

51 148
299 morphine effect on LGU in brain [photographs, negative], undated

51 149
300 morphine effect on LGU in brain [photographs, negative], undated

51 150
301 fetal sheep [photographs, negative], undated

51 151
302 fetal sheep [photographs, negative], undated

51 152
303 morphine vs. control tail flick [photographs, negative], undated

51 153
304 average rate of GU for entire brain of fetal and newborn sheep, undated

51 154
305 chemical analysis of 14C DG and 14C DG-L-P in normal rats [photographs, negative], undated

51 155
306 extinction -- Icss [photographs, negative], undated

51 156
307 PCO2 and LCGU relationship [photographs, negative], undated

51 157
308 habenula afferent and efferent pathways [photographs, negative], undated

51 158
309 LGU in laboratory animals [photographs, negative], undated

51 159
310 time course of 14C DG and 14C DG-6-P [photographs, negative], undated

51